Sex differences in type 2 diabetes
The prevalence of type 2 diabetes mellitus is increasing in both sexes, but men are usually diagnosed at a younger age and lower body fat mass than women. Worldwide, an estimated 17.7 million more men than women have diabetes mellitus. Women appear to bear a greater risk factor burden at the time of...
Saved in:
| Published in: | Diabetologia Vol. 66; no. 6; pp. 986 - 1002 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.06.2023
Springer Nature B.V |
| Subjects: | |
| ISSN: | 0012-186X, 1432-0428, 1432-0428 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | The prevalence of type 2 diabetes mellitus is increasing in both sexes, but men are usually diagnosed at a younger age and lower body fat mass than women. Worldwide, an estimated 17.7 million more men than women have diabetes mellitus. Women appear to bear a greater risk factor burden at the time of their type 2 diabetes diagnosis, especially obesity. Moreover, psychosocial stress might play a more prominent role in diabetes risk in women. Across their lifespan, women experience greater hormone fluctuations and body changes due to reproductive factors than men. Pregnancies can unmask pre-existing metabolic abnormalities, resulting in the diagnosis of gestational diabetes, which appears to be the most prominent risk factor for progression to type 2 diabetes in women. Additionally, menopause increases women’s cardiometabolic risk profile. Due to the progressive rise in obesity, there is a global increase in women with pregestational type 2 diabetes, often with inadequate preconceptual care. There are differences between men and women regarding type 2 diabetes and other cardiovascular risk factors with respect to comorbidities, the manifestation of complications and the initiation of and adherence to therapy. Women with type 2 diabetes show greater relative risk of CVD and mortality than men. Moreover, young women with type 2 diabetes are currently less likely than men to receive the treatment and CVD risk reduction recommended by guidelines. Current medical recommendations do not provide information on sex-specific or gender-sensitive prevention strategies and management. Thus, more research on sex differences, including the underlying mechanisms, is necessary to increase the evidence in the future. Nonetheless, intensified efforts to screen for glucose metabolism disorders and other cardiovascular risk factors, as well as the early establishment of prophylactic measures and aggressive risk management strategies, are still required for both men and women at increased risk of type 2 diabetes. In this narrative review we aim to summarise sex-specific clinical features and differences between women and men with type 2 diabetes into risk factors, screening, diagnosis, complications and treatment.
Graphical abstract |
|---|---|
| AbstractList | The prevalence of type 2 diabetes mellitus is increasing in both sexes, but men are usually diagnosed at a younger age and lower body fat mass than women. Worldwide, an estimated 17.7 million more men than women have diabetes mellitus. Women appear to bear a greater risk factor burden at the time of their type 2 diabetes diagnosis, especially obesity. Moreover, psychosocial stress might play a more prominent role in diabetes risk in women. Across their lifespan, women experience greater hormone fluctuations and body changes due to reproductive factors than men. Pregnancies can unmask pre-existing metabolic abnormalities, resulting in the diagnosis of gestational diabetes, which appears to be the most prominent risk factor for progression to type 2 diabetes in women. Additionally, menopause increases women's cardiometabolic risk profile. Due to the progressive rise in obesity, there is a global increase in women with pregestational type 2 diabetes, often with inadequate preconceptual care. There are differences between men and women regarding type 2 diabetes and other cardiovascular risk factors with respect to comorbidities, the manifestation of complications and the initiation of and adherence to therapy. Women with type 2 diabetes show greater relative risk of CVD and mortality than men. Moreover, young women with type 2 diabetes are currently less likely than men to receive the treatment and CVD risk reduction recommended by guidelines. Current medical recommendations do not provide information on sex-specific or gender-sensitive prevention strategies and management. Thus, more research on sex differences, including the underlying mechanisms, is necessary to increase the evidence in the future. Nonetheless, intensified efforts to screen for glucose metabolism disorders and other cardiovascular risk factors, as well as the early establishment of prophylactic measures and aggressive risk management strategies, are still required for both men and women at increased risk of type 2 diabetes. In this narrative review we aim to summarise sex-specific clinical features and differences between women and men with type 2 diabetes into risk factors, screening, diagnosis, complications and treatment.The prevalence of type 2 diabetes mellitus is increasing in both sexes, but men are usually diagnosed at a younger age and lower body fat mass than women. Worldwide, an estimated 17.7 million more men than women have diabetes mellitus. Women appear to bear a greater risk factor burden at the time of their type 2 diabetes diagnosis, especially obesity. Moreover, psychosocial stress might play a more prominent role in diabetes risk in women. Across their lifespan, women experience greater hormone fluctuations and body changes due to reproductive factors than men. Pregnancies can unmask pre-existing metabolic abnormalities, resulting in the diagnosis of gestational diabetes, which appears to be the most prominent risk factor for progression to type 2 diabetes in women. Additionally, menopause increases women's cardiometabolic risk profile. Due to the progressive rise in obesity, there is a global increase in women with pregestational type 2 diabetes, often with inadequate preconceptual care. There are differences between men and women regarding type 2 diabetes and other cardiovascular risk factors with respect to comorbidities, the manifestation of complications and the initiation of and adherence to therapy. Women with type 2 diabetes show greater relative risk of CVD and mortality than men. Moreover, young women with type 2 diabetes are currently less likely than men to receive the treatment and CVD risk reduction recommended by guidelines. Current medical recommendations do not provide information on sex-specific or gender-sensitive prevention strategies and management. Thus, more research on sex differences, including the underlying mechanisms, is necessary to increase the evidence in the future. Nonetheless, intensified efforts to screen for glucose metabolism disorders and other cardiovascular risk factors, as well as the early establishment of prophylactic measures and aggressive risk management strategies, are still required for both men and women at increased risk of type 2 diabetes. In this narrative review we aim to summarise sex-specific clinical features and differences between women and men with type 2 diabetes into risk factors, screening, diagnosis, complications and treatment. The prevalence of type 2 diabetes mellitus is increasing in both sexes, but men are usually diagnosed at a younger age and lower body fat mass than women. Worldwide, an estimated 17.7 million more men than women have diabetes mellitus. Women appear to bear a greater risk factor burden at the time of their type 2 diabetes diagnosis, especially obesity. Moreover, psychosocial stress might play a more prominent role in diabetes risk in women. Across their lifespan, women experience greater hormone fluctuations and body changes due to reproductive factors than men. Pregnancies can unmask pre-existing metabolic abnormalities, resulting in the diagnosis of gestational diabetes, which appears to be the most prominent risk factor for progression to type 2 diabetes in women. Additionally, menopause increases women’s cardiometabolic risk profile. Due to the progressive rise in obesity, there is a global increase in women with pregestational type 2 diabetes, often with inadequate preconceptual care. There are differences between men and women regarding type 2 diabetes and other cardiovascular risk factors with respect to comorbidities, the manifestation of complications and the initiation of and adherence to therapy. Women with type 2 diabetes show greater relative risk of CVD and mortality than men. Moreover, young women with type 2 diabetes are currently less likely than men to receive the treatment and CVD risk reduction recommended by guidelines. Current medical recommendations do not provide information on sex-specific or gender-sensitive prevention strategies and management. Thus, more research on sex differences, including the underlying mechanisms, is necessary to increase the evidence in the future. Nonetheless, intensified efforts to screen for glucose metabolism disorders and other cardiovascular risk factors, as well as the early establishment of prophylactic measures and aggressive risk management strategies, are still required for both men and women at increased risk of type 2 diabetes. In this narrative review we aim to summarise sex-specific clinical features and differences between women and men with type 2 diabetes into risk factors, screening, diagnosis, complications and treatment. The prevalence of type 2 diabetes mellitus is increasing in both sexes, but men are usually diagnosed at a younger age and lower body fat mass than women. Worldwide, an estimated 17.7 million more men than women have diabetes mellitus. Women appear to bear a greater risk factor burden at the time of their type 2 diabetes diagnosis, especially obesity. Moreover, psychosocial stress might play a more prominent role in diabetes risk in women. Across their lifespan, women experience greater hormone fluctuations and body changes due to reproductive factors than men. Pregnancies can unmask pre-existing metabolic abnormalities, resulting in the diagnosis of gestational diabetes, which appears to be the most prominent risk factor for progression to type 2 diabetes in women. Additionally, menopause increases women’s cardiometabolic risk profile. Due to the progressive rise in obesity, there is a global increase in women with pregestational type 2 diabetes, often with inadequate preconceptual care. There are differences between men and women regarding type 2 diabetes and other cardiovascular risk factors with respect to comorbidities, the manifestation of complications and the initiation of and adherence to therapy. Women with type 2 diabetes show greater relative risk of CVD and mortality than men. Moreover, young women with type 2 diabetes are currently less likely than men to receive the treatment and CVD risk reduction recommended by guidelines. Current medical recommendations do not provide information on sex-specific or gender-sensitive prevention strategies and management. Thus, more research on sex differences, including the underlying mechanisms, is necessary to increase the evidence in the future. Nonetheless, intensified efforts to screen for glucose metabolism disorders and other cardiovascular risk factors, as well as the early establishment of prophylactic measures and aggressive risk management strategies, are still required for both men and women at increased risk of type 2 diabetes. In this narrative review we aim to summarise sex-specific clinical features and differences between women and men with type 2 diabetes into risk factors, screening, diagnosis, complications and treatment. The prevalence of type 2 diabetes mellitus is increasing in both sexes, but men are usually diagnosed at a younger age and lower body fat mass than women. Worldwide, an estimated 17.7 million more men than women have diabetes mellitus. Women appear to bear a greater risk factor burden at the time of their type 2 diabetes diagnosis, especially obesity. Moreover, psychosocial stress might play a more prominent role in diabetes risk in women. Across their lifespan, women experience greater hormone fluctuations and body changes due to reproductive factors than men. Pregnancies can unmask pre-existing metabolic abnormalities, resulting in the diagnosis of gestational diabetes, which appears to be the most prominent risk factor for progression to type 2 diabetes in women. Additionally, menopause increases women’s cardiometabolic risk profile. Due to the progressive rise in obesity, there is a global increase in women with pregestational type 2 diabetes, often with inadequate preconceptual care. There are differences between men and women regarding type 2 diabetes and other cardiovascular risk factors with respect to comorbidities, the manifestation of complications and the initiation of and adherence to therapy. Women with type 2 diabetes show greater relative risk of CVD and mortality than men. Moreover, young women with type 2 diabetes are currently less likely than men to receive the treatment and CVD risk reduction recommended by guidelines. Current medical recommendations do not provide information on sex-specific or gender-sensitive prevention strategies and management. Thus, more research on sex differences, including the underlying mechanisms, is necessary to increase the evidence in the future. Nonetheless, intensified efforts to screen for glucose metabolism disorders and other cardiovascular risk factors, as well as the early establishment of prophylactic measures and aggressive risk management strategies, are still required for both men and women at increased risk of type 2 diabetes. In this narrative review we aim to summarise sex-specific clinical features and differences between women and men with type 2 diabetes into risk factors, screening, diagnosis, complications and treatment. Graphical abstract |
| Author | Leutner, Michael Harreiter, Jürgen Kautzky-Willer, Alexandra |
| Author_xml | – sequence: 1 givenname: Alexandra orcidid: 0000-0002-3520-4105 surname: Kautzky-Willer fullname: Kautzky-Willer, Alexandra email: alexandra.kautzky-willer@meduniwien.ac.at organization: Department of Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, Gender Institute, Lapura Women’s Health Resort – sequence: 2 givenname: Michael orcidid: 0000-0003-3959-1496 surname: Leutner fullname: Leutner, Michael organization: Department of Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna – sequence: 3 givenname: Jürgen orcidid: 0000-0003-2508-9403 surname: Harreiter fullname: Harreiter, Jürgen organization: Department of Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36897358$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUFPGzEQhS0EghD6B3qoovbCZantsb32qUKotEhIHCgSN8vrnaVGG29qb6rw7-uQQIEDp5Fmvvf07HdIduMQkZCPjJ4wSuuvmVLGZUU5VFRqw6rVDpkwAbyigutdMlnfK6bV7QE5zPmeUgpSqH1yAEqbGqSekM_XuJq1oeswYfSYZyHOxocFznjZugZHzEdkr3N9xg_bOSU3599_nf2sLq9-XJydXlZe1HKsGskdcAGdkYZ54VuBom2cagwo5zkDSesWUCN0CNBIpVHKzgmNnTNMtTAl3za-i2Uzx9ZjHJPr7SKFuUsPdnDBvr7E8NveDX8to0wBA1McjrcOafizxDzaecge-95FHJbZ8loraqSWuqBf3qD3wzLF8j7LNTVGMU1FoT69jPSc5en_CqA3gE9Dzgk768PoxjCsE4a-RLPrquymKluqso9V2VWR8jfSJ_d3RbAR5QLHO0z_Y7-j-gdYWKUq |
| CitedBy_id | crossref_primary_10_1016_j_obmed_2024_100570 crossref_primary_10_1038_s44324_025_00065_2 crossref_primary_10_3390_ijms26020862 crossref_primary_10_1016_j_jss_2024_09_017 crossref_primary_10_1177_26350106241256324 crossref_primary_10_2337_dc23_2153 crossref_primary_10_1038_s41598_024_79329_8 crossref_primary_10_4081_reumatismo_2024_1769 crossref_primary_10_1007_s00125_024_06113_8 crossref_primary_10_3389_fendo_2024_1417240 crossref_primary_10_1111_bph_70164 crossref_primary_10_1111_jdi_14308 crossref_primary_10_1111_dom_15763 crossref_primary_10_2147_DMSO_S497309 crossref_primary_10_31436_ijcs_v8i1_410 crossref_primary_10_1016_j_fjurol_2025_102936 crossref_primary_10_1007_s40520_025_03008_5 crossref_primary_10_1016_j_molmet_2025_102185 crossref_primary_10_1002_ame2_70023 crossref_primary_10_1249_MSS_0000000000003639 crossref_primary_10_3390_biom14030306 crossref_primary_10_3238_PersDia_2025_06_27_02 crossref_primary_10_1186_s12967_025_06437_y crossref_primary_10_1097_JP9_0000000000000205 crossref_primary_10_1016_j_atherosclerosis_2024_117500 crossref_primary_10_3390_pharmaceutics16040454 crossref_primary_10_1007_s11298_024_3827_6 crossref_primary_10_14814_phy2_70536 crossref_primary_10_1038_s42003_025_07709_5 crossref_primary_10_1016_j_biopha_2023_115219 crossref_primary_10_3389_fpubh_2025_1515797 crossref_primary_10_1007_s00484_025_02854_2 crossref_primary_10_1038_s44294_025_00080_0 crossref_primary_10_1186_s12610_025_00257_2 crossref_primary_10_3389_fphys_2025_1547901 crossref_primary_10_1002_ana_27135 crossref_primary_10_3389_fmicb_2024_1421608 crossref_primary_10_1186_s12902_025_01940_1 crossref_primary_10_1002_ajhb_24119 crossref_primary_10_1016_j_inffus_2025_103741 crossref_primary_10_1038_s41574_024_01058_9 crossref_primary_10_3390_jcm14124030 crossref_primary_10_1038_s41574_024_01012_9 crossref_primary_10_2337_dc24_2459 crossref_primary_10_3390_ph18010128 crossref_primary_10_1038_s41598_025_96308_9 crossref_primary_10_1016_j_jacl_2025_08_010 crossref_primary_10_1111_dom_15741 crossref_primary_10_1038_s42256_025_01086_8 crossref_primary_10_1186_s12933_024_02246_7 crossref_primary_10_1093_lifemeta_loaf011 crossref_primary_10_1371_journal_pone_0300966 crossref_primary_10_1371_journal_pone_0293681 crossref_primary_10_1186_s12933_024_02438_1 crossref_primary_10_1016_j_mad_2025_112081 crossref_primary_10_1111_1753_0407_70001 crossref_primary_10_3390_ijms26104777 crossref_primary_10_4236_ojmm_2025_153012 crossref_primary_10_1371_journal_pntd_0012975 crossref_primary_10_1016_j_pcd_2025_07_001 crossref_primary_10_1016_j_sciaf_2025_e02775 crossref_primary_10_3390_ijms242417406 crossref_primary_10_1177_1934578X251323393 crossref_primary_10_1159_000543404 crossref_primary_10_3390_ijms25179681 crossref_primary_10_3390_jcm13041108 crossref_primary_10_1111_dom_15635 crossref_primary_10_1186_s12889_025_23576_5 crossref_primary_10_1210_clinem_dgae557 crossref_primary_10_1038_s44294_024_00041_z crossref_primary_10_1016_j_jdiacomp_2024_108815 crossref_primary_10_3390_biomedicines13081842 crossref_primary_10_1039_D4FO04498C crossref_primary_10_2196_78001 crossref_primary_10_1371_journal_pone_0311320 crossref_primary_10_1016_j_semarthrit_2025_152790 crossref_primary_10_3390_jcm13237443 crossref_primary_10_1016_j_jacadv_2025_101791 crossref_primary_10_3390_nu17142349 crossref_primary_10_1007_s13300_023_01482_6 crossref_primary_10_1186_s12933_024_02371_3 crossref_primary_10_3390_jcm12093288 crossref_primary_10_1038_s41598_025_07743_7 crossref_primary_10_1186_s12902_024_01641_1 crossref_primary_10_1016_j_bspc_2025_107983 crossref_primary_10_5694_mja2_70032 crossref_primary_10_1016_j_mjafi_2025_02_008 crossref_primary_10_1002_14651858_CD016154 crossref_primary_10_1080_13543784_2024_2321271 crossref_primary_10_1186_s13041_024_01124_3 crossref_primary_10_1038_s41433_025_03956_2 crossref_primary_10_1016_j_clnu_2025_04_018 crossref_primary_10_1038_s41598_025_07671_6 crossref_primary_10_1038_s41380_025_03083_0 crossref_primary_10_1192_bjo_2024_764 crossref_primary_10_3904_kjim_2024_077 crossref_primary_10_1080_17512433_2025_2527092 crossref_primary_10_1016_j_metabol_2024_156038 crossref_primary_10_2147_DMSO_S537229 crossref_primary_10_1016_j_ajpc_2025_100928 crossref_primary_10_1016_j_jesf_2023_08_003 crossref_primary_10_1186_s12889_025_21940_z crossref_primary_10_1007_s15034_023_4478_5 crossref_primary_10_3390_pathophysiology32010012 crossref_primary_10_1016_j_health_2025_100390 crossref_primary_10_1016_S2468_2667_24_00250_0 crossref_primary_10_1186_s13293_025_00714_7 crossref_primary_10_3346_jkms_2025_40_e241 crossref_primary_10_3389_fpsyt_2025_1608601 crossref_primary_10_1016_j_diabres_2024_111907 crossref_primary_10_1016_j_jstrokecerebrovasdis_2024_107768 crossref_primary_10_1016_j_cmet_2024_01_002 crossref_primary_10_1161_ATVBAHA_124_321629 crossref_primary_10_1210_clinem_dgae051 crossref_primary_10_1186_s40816_025_00395_0 crossref_primary_10_1111_cen_15253 crossref_primary_10_1016_j_diabres_2024_111937 crossref_primary_10_3390_nu16101408 crossref_primary_10_1016_j_ijnurstu_2025_105034 crossref_primary_10_1056_NEJMoa2501006 crossref_primary_10_1002_oby_24297 crossref_primary_10_1186_s12933_025_02717_5 crossref_primary_10_1186_s12902_024_01665_7 crossref_primary_10_1111_dom_15541 crossref_primary_10_3389_fendo_2025_1475323 crossref_primary_10_1111_aji_70139 crossref_primary_10_1093_ejendo_lvae166 crossref_primary_10_3389_fendo_2023_1285637 crossref_primary_10_1016_j_clnesp_2025_03_169 crossref_primary_10_1177_1357633X251314290 crossref_primary_10_3390_jcm13164752 crossref_primary_10_1016_j_envres_2024_118965 crossref_primary_10_1186_s44167_024_00066_4 crossref_primary_10_1124_jpet_124_002150 crossref_primary_10_1016_j_jacadv_2025_101882 crossref_primary_10_32388_76QMHB_2 crossref_primary_10_1016_j_jchf_2025_02_015 crossref_primary_10_3390_ijerph22040519 crossref_primary_10_1111_bph_70035 crossref_primary_10_1186_s12889_024_19395_9 crossref_primary_10_1155_2024_2527791 crossref_primary_10_3390_antiox13010006 crossref_primary_10_1111_jdi_14405 crossref_primary_10_1515_teb_2024_2007 crossref_primary_10_3897_pharmacia_71_e117126 crossref_primary_10_1016_j_metabol_2025_156241 crossref_primary_10_2147_DMSO_S432331 crossref_primary_10_3389_fendo_2024_1330650 crossref_primary_10_3389_fmicb_2024_1451054 crossref_primary_10_4103_ijdr_ijdr_924_23 crossref_primary_10_1007_s12020_025_04217_8 crossref_primary_10_1016_j_ypmed_2025_108407 crossref_primary_10_1007_s12181_024_00694_9 crossref_primary_10_1371_journal_pone_0302535 crossref_primary_10_3389_fonc_2024_1471699 crossref_primary_10_1007_s12020_024_03874_5 crossref_primary_10_1007_s00592_025_02512_4 crossref_primary_10_1097_MCG_0000000000002079 crossref_primary_10_34922_AE_2025_38_2_012 crossref_primary_10_1007_s00125_025_06511_6 crossref_primary_10_1111_bph_17327 crossref_primary_10_1186_s12933_024_02494_7 crossref_primary_10_1016_j_nutres_2024_09_008 crossref_primary_10_1038_s41598_025_96076_6 crossref_primary_10_1515_jom_2025_0044 crossref_primary_10_3390_ijms242015078 crossref_primary_10_1007_s00125_024_06144_1 crossref_primary_10_1038_s41598_025_06290_5 crossref_primary_10_3390_ijms25031816 crossref_primary_10_1001_jamanetworkopen_2024_27569 crossref_primary_10_1016_j_mbm_2025_100132 crossref_primary_10_3390_jcm14092868 crossref_primary_10_1371_journal_pone_0321069 crossref_primary_10_70322_fibrosis_2024_10006 crossref_primary_10_1186_s40779_025_00615_1 crossref_primary_10_1186_s12933_023_01980_8 crossref_primary_10_3389_fendo_2025_1513641 crossref_primary_10_1016_j_arr_2024_102405 crossref_primary_10_3390_jcm14165644 crossref_primary_10_1038_s41598_025_94694_8 crossref_primary_10_1371_journal_pone_0309153 crossref_primary_10_3390_toxics13010009 crossref_primary_10_1186_s12933_024_02275_2 crossref_primary_10_2337_dc23_0937 crossref_primary_10_1177_0976500X241306180 crossref_primary_10_1001_jamanetworkopen_2025_33193 crossref_primary_10_1155_2024_5558665 crossref_primary_10_3389_fendo_2023_1274025 crossref_primary_10_1007_s11428_025_01304_2 crossref_primary_10_1016_S2214_109X_24_00520_5 crossref_primary_10_1186_s13098_024_01533_3 crossref_primary_10_1007_s11920_025_01601_z crossref_primary_10_4103_jopsys_jopsys_33_25 crossref_primary_10_1016_j_cardfail_2025_01_008 crossref_primary_10_3389_fpubh_2025_1536627 crossref_primary_10_1038_s41598_025_96175_4 crossref_primary_10_3390_toxics11100877 crossref_primary_10_3389_fendo_2023_1298345 crossref_primary_10_3390_ijms25179288 crossref_primary_10_1007_s12020_024_04012_x crossref_primary_10_25259_ijn_559_23 crossref_primary_10_1016_j_intimp_2025_115467 crossref_primary_10_4103_njcp_njcp_88_24 crossref_primary_10_3390_ijms26052153 crossref_primary_10_36489_saudecoletiva_2025v15i95p15626_15641 crossref_primary_10_1038_s41366_024_01501_x crossref_primary_10_33925_1683_3759_2025_1050 crossref_primary_10_1111_dom_15598 crossref_primary_10_1161_CIRCRESAHA_123_323182 crossref_primary_10_1177_07487304241309165 crossref_primary_10_1093_ej_ueaf025 crossref_primary_10_3390_biomedicines12040823 crossref_primary_10_1093_gerona_glaf095 crossref_primary_10_7570_jomes24029 crossref_primary_10_1007_s12020_025_04353_1 crossref_primary_10_1111_hex_70108 crossref_primary_10_2147_PROM_S538578 crossref_primary_10_34133_research_0683 crossref_primary_10_3390_ijms25147665 crossref_primary_10_1089_met_2024_0100 crossref_primary_10_1177_07334648251343924 crossref_primary_10_1152_japplphysiol_00467_2025 crossref_primary_10_1007_s13410_024_01369_7 crossref_primary_10_1136_jech_2023_221759 crossref_primary_10_1210_clinem_dgae584 crossref_primary_10_1038_s41598_023_35806_0 crossref_primary_10_7759_cureus_66543 crossref_primary_10_14710_jnc_v14i2_44440 crossref_primary_10_1007_s00394_024_03463_2 crossref_primary_10_1016_j_fbio_2025_106499 crossref_primary_10_3389_fendo_2024_1339879 crossref_primary_10_1093_ehjdh_ztaf071 crossref_primary_10_1111_jdi_70102 crossref_primary_10_22159_ajpcr_2025v18i7_54957 crossref_primary_10_1016_j_pop_2025_01_005 crossref_primary_10_1007_s11154_025_09983_4 crossref_primary_10_1371_journal_pone_0306401 crossref_primary_10_1152_ajpcell_00098_2025 crossref_primary_10_1016_j_diabres_2025_112335 crossref_primary_10_1111_jdi_14229 crossref_primary_10_1007_s11606_024_08860_1 crossref_primary_10_3390_dietetics4030036 crossref_primary_10_1111_dom_70081 crossref_primary_10_3390_nu16183063 crossref_primary_10_1152_ajpheart_00193_2025 crossref_primary_10_1161_CIRCRESAHA_124_325918 crossref_primary_10_1016_j_lana_2024_100699 crossref_primary_10_1007_s11560_023_00694_y crossref_primary_10_5993_AJHB_48_1_5 crossref_primary_10_1097_MD_0000000000040212 crossref_primary_10_1016_j_avsg_2024_07_105 crossref_primary_10_3390_biomedicines13040855 crossref_primary_10_1016_j_heares_2024_109072 crossref_primary_10_1002_jbm4_10839 crossref_primary_10_1371_journal_pone_0327305 crossref_primary_10_1155_jdr_3733178 crossref_primary_10_1371_journal_pone_0330935 crossref_primary_10_1186_s12916_024_03540_7 crossref_primary_10_1210_jendso_bvaf048 crossref_primary_10_4239_wjd_v15_i11_2167 crossref_primary_10_1186_s13293_023_00571_2 crossref_primary_10_1016_j_diabres_2025_112112 crossref_primary_10_3390_cimb46110736 crossref_primary_10_1080_0886022X_2024_2398188 crossref_primary_10_3389_fendo_2025_1580036 crossref_primary_10_3389_fnut_2025_1581009 crossref_primary_10_1093_gerona_glae246 crossref_primary_10_1080_17474086_2024_2383417 crossref_primary_10_1080_17512433_2024_2306223 crossref_primary_10_1186_s12879_024_09404_y crossref_primary_10_1186_s12883_025_04044_4 crossref_primary_10_1016_j_fbio_2024_103716 |
| Cites_doi | 10.1055/s-0035-1559608 10.1111/joim.12567 10.2337/dc20-1137 10.1089/jwh.2012.3972 10.2337/dci21-0059 10.2337/dc22-0013 10.1111/dom.13607 10.1007/s11892-020-01348-2 10.1007/s11892-018-1040-2 10.1186/s12933-021-01233-6 10.1136/bmjopen-2014-005892 10.1136/bmjdrc-2021-002707 10.1007/s00125-014-3344-3 10.2337/db14-1751 10.2337/dc20-1112 10.1136/bmjdrc-2020-001430 10.1007/s00125-020-05169-6 10.1530/EJE-18-0792 10.2337/dc18-0344 10.1507/endocrj.k09e-003 10.1038/s41591-019-0563-7 10.1007/s11096-009-9303-2 10.1056/NEJMoa050613 10.1186/s12933-021-01290-x 10.1002/hep.32560 10.1155/2016/4626382 10.1371/journal.pgen.1008405 10.1530/EJE-21-0721 10.1016/S0140-6736(20)31561-0 10.1016/j.sxmr.2019.06.006 10.2337/dc18-2029 10.1007/s00125-022-05790-7 10.1210/jc.2014-3761 10.1016/j.jdiacomp.2013.04.012 10.1016/j.ebiom.2022.104259 10.1210/er.2012-1055 10.1007/s00125-016-4162-6 10.1016/j.diabres.2017.07.012 10.1111/dom.12449 10.1002/clc.22917 10.1001/jamanetworkopen.2021.6139 10.2337/dc22-S004 10.2337/dc13-0219 10.1016/j.diabres.2020.108452 10.1016/j.jdiacomp.2007.06.009 10.1038/s41574-020-00431-8 10.1186/s12933-020-01133-1 10.1111/dom.13876 10.1007/s13300-018-0492-3 10.1080/07420528.2020.1804923 10.1111/dme.12478 10.1161/CIRCULATIONAHA.119.044491 10.1056/NEJMoa1908655 10.3389/fmed.2021.608083 10.1038/s41598-020-74000-4 10.1007/s00125-019-4926-x 10.1007/s00125-019-4955-5 10.1016/S0140-6736(14)61368-4 10.1001/jama.2018.0423 10.1507/endocrj.EJ20-0630 10.2337/diacare.26.1.61 10.1210/clinem/dgab757 10.1016/S2213-8587(22)00252-2 10.1016/j.diabres.2020.108625 10.1001/jamacardio.2019.5306 10.1530/JOE-18-0573 10.1016/j.jdiacomp.2016.01.013 10.1186/s13293-021-00366-3 10.2337/db05-1620 10.1038/s41591-020-1126-7 10.1111/dme.14395 10.1161/CIRCULATIONAHA.122.059755 10.1007/s00125-003-1096-6 10.2337/dc06-0438 10.1136/annrheumdis-2019-215714 10.1186/1471-2458-12-392 10.1161/JAHA.119.012940 10.1111/dme.13448 10.1530/EJE-18-0602 10.1093/eurheartj/ehz913 10.1186/s12916-019-1428-0 10.1016/j.mce.2021.111365 10.1016/j.diabres.2022.110027 10.1007/s00125-019-05040-3 10.2337/dc14-1306 10.1161/CIRCULATIONAHA.118.039100 10.1210/jc.2010-1398 10.1210/jc.2008-0772 10.1172/JCI140223 10.2337/diabetes.52.2.244 10.1016/S2213-8587(20)30367-3 10.1016/j.dsx.2020.02.012 10.1080/07420528.2019.1683570 10.1186/s12933-022-01713-3 10.1186/s12916-019-1355-0 10.2337/dc19-2257 10.3389/fendo.2018.00220 10.1155/2018/5406128 10.1007/s00592-018-1132-0 10.1007/s12020-016-1014-6 10.1371/journal.pone.0243797 10.1016/j.diabres.2013.12.043 10.1177/2047487319834396 10.1056/NEJMoa2206286 10.1007/s13300-018-0470-9 10.1507/endocrj.EJ16-0552 10.1089/dia.2014.0412 10.2147/dmso.S42729 10.2174/1573399817666210827121937 10.2337/dc21-1071 10.1016/j.jcmg.2014.04.019 10.1136/bmj.38678.389583.7C 10.1016/S2213-8587(17)30336-4 10.2337/dc06-0454 10.1186/s12939-015-0245-0 10.1038/s41572-019-0098-8 10.2337/dc12-1738 10.1016/j.jns.2018.03.008 10.1210/er.2015-1137 10.1016/S0735-1097(18)31618-8 10.1111/dom.13086 10.1016/S2213-8587(18)30079-2 10.1007/s00125-017-4301-8 10.1152/ajpregu.00864.2007 10.1007/s00125-021-05583-4 10.1038/nrendo.2018.24 10.1007/s10654-018-0433-5 10.1001/jama.1996.03530440037034 10.1007/s00125-022-05811-5 10.7326/M21-4389 10.1038/s41575-021-00551-0 10.1161/CIRCULATIONAHA.118.034271 10.1007/s00125-019-4896-z 10.1136/bmj.m2297 10.1038/s41591-019-0643-8 10.7326/M19-0085 10.1016/j.phrs.2017.01.023 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023. corrected publication 2023 2023. The Author(s). The Author(s) 2023. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2023, corrected publication 2023 |
| Copyright_xml | – notice: The Author(s) 2023. corrected publication 2023 – notice: 2023. The Author(s). – notice: The Author(s) 2023. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2023, corrected publication 2023 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1007/s00125-023-05891-x |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest One Academic Middle East (New) CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1432-0428 |
| EndPage | 1002 |
| ExternalDocumentID | PMC10163139 36897358 10_1007_s00125_023_05891_x |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: GENDER-NET Plus ERA-NET Initiative grantid: GOING-FWD funded by the GENDER-NET Plus ERA-NET In – fundername: Austrian Science Fund FWF grantid: I 4209 – fundername: ; grantid: GOING-FWD funded by the GENDER-NET Plus ERA-NET In |
| GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1CY 1N0 1SB 2.D 203 28- 29F 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X A8Z AAAVM AABHQ AACDK AAEWM AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDYV AFEXP AFFNX AFJLC AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI C6C CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z J5H JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LLZTM M1P M4Y MA- MVM N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P6G P9S PF0 PQQKQ PROAC PSQYO PT4 Q2X QOK QOR QOS R4E R89 R9I RHV RIG ROL RPX RRX RSV S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TR2 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK8 X7M YLTOR Z45 Z7U Z7V Z7W Z82 Z83 Z87 Z8O Z8P Z8Q Z8V Z8W Z91 Z92 ZGI ZMTXR ZOVNA ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7T5 7XB 8FK H94 K9. PKEHL PQEST PQUKI PRINS 7X8 ESTFP PUEGO 5PM |
| ID | FETCH-LOGICAL-c475t-b52a3243f9591c4cd4e4dba6b936ac213507d3e8e3fe33b568e55fa48efa916d3 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 330 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000947275800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0012-186X 1432-0428 |
| IngestDate | Tue Nov 04 02:06:54 EST 2025 Mon Sep 08 11:08:13 EDT 2025 Thu Nov 27 13:52:04 EST 2025 Sat Aug 02 01:41:12 EDT 2025 Tue Nov 18 22:28:11 EST 2025 Sat Nov 29 02:07:47 EST 2025 Fri Feb 21 02:45:44 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Type 2 diabetes Therapy Macrovascular complications Cardiovascular mortality Sex Gender Review Microvascular complications Risk factors |
| Language | English |
| License | 2023. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c475t-b52a3243f9591c4cd4e4dba6b936ac213507d3e8e3fe33b568e55fa48efa916d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0003-2508-9403 0000-0003-3959-1496 0000-0002-3520-4105 |
| OpenAccessLink | https://link.springer.com/10.1007/s00125-023-05891-x |
| PMID | 36897358 |
| PQID | 2809961804 |
| PQPubID | 48469 |
| PageCount | 17 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10163139 proquest_miscellaneous_2786095858 proquest_journals_2809961804 pubmed_primary_36897358 crossref_citationtrail_10_1007_s00125_023_05891_x crossref_primary_10_1007_s00125_023_05891_x springer_journals_10_1007_s00125_023_05891_x |
| PublicationCentury | 2000 |
| PublicationDate | 2023-06-01 |
| PublicationDateYYYYMMDD | 2023-06-01 |
| PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationSubtitle | Clinical, Translational and Experimental Diabetes and Metabolism |
| PublicationTitle | Diabetologia |
| PublicationTitleAbbrev | Diabetologia |
| PublicationTitleAlternate | Diabetologia |
| PublicationYear | 2023 |
| Publisher | Springer Berlin Heidelberg Springer Nature B.V |
| Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
| References | PuriRNissenSEShaoMSex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURNJACC Cardiovasc Imaging20147101013102210.1016/j.jcmg.2014.04.01925240453 GoossensGHJockenJWEBlaakEESexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liverNat Rev Endocrinol2021171476610.1038/s41574-020-00431-833173188 AnichiniRCosimiSDi CarloAGender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experienceDiabetes Metab Syndr Obes201361231291:CAS:528:DC%2BC3sXosVSnurw%3D10.2147/dmso.S42729236304273626369 RidkerPMCookNRLeeIMA randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in womenN Engl J Med200535213129313041:CAS:528:DC%2BD2MXislCjs7Y%3D10.1056/NEJMoa05061315753114 Prospective Studies Collaboration, Asia Pacific Cohort Studies CollaborationSex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studiesLancet Diabetes Endocrinol20186753854610.1016/S2213-8587(18)30079-2 TramuntBSmatiSGrandgeorgeNSex differences in metabolic regulation and diabetes susceptibilityDiabetologia202063345346110.1007/s00125-019-05040-331754750 WrightAKWelshPGillJMRAge-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetesDiabetologia2020638154215531:CAS:528:DC%2BB3cXpvVanur0%3D10.1007/s00125-020-05169-6324358217351865 Kautzky-WillerAHarreiterJPaciniGSex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitusEndocr Rev20163732783161:CAS:528:DC%2BC1cXkt1Oqs7w%3D10.1210/er.2015-1137271598754890267 HuGDecode Study GroupGender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetesDiabetologia20034656086171:STN:280:DC%2BD3s3ot12ltQ%3D%3D10.1007/s00125-003-1096-612750769 DennisJMHenleyWEWeedonMNSex and BMI alter the benefits and risks of sulfonylureas and thiazolidinediones in type 2 diabetes: a framework for evaluating stratification using routine clinical and individual trial dataDiabetes Care20184191844185310.2337/dc18-034430072404 Kautzky-WillerAKrssakMWinzerCIncreased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetesDiabetes20035222442511:CAS:528:DC%2BD3sXhtFagu7o%3D10.2337/diabetes.52.2.24412540593 CaiXZhangYLiMAssociation between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysisBMJ2020370m229710.1136/bmj.m2297326692827362233 FunckKLBjergLIsaksenAASandbaekAGroveELGender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a Danish nationwide cohort studyCardiovasc Diabetol20222112791:CAS:528:DC%2BB38XjtFSmtbvL10.1186/s12933-022-01713-3364964029737743 TomicDMortonJIChenLLifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based studyLancet Diabetes Endocrinol2022101179580310.1016/S2213-8587(22)00252-236183736 de HauteclocqueARagotSSlaouiYThe influence of sex on renal function decline in people with Type 2 diabetesDiabet Med2014319112111281:CAS:528:DC%2BC2cXhsVSrurrK10.1111/dme.1247824773061 McIntyreHDCatalanoPZhangCDesoyeGMathiesenERDammPGestational diabetes mellitusNat Rev Dis Primers2019514710.1038/s41572-019-0098-831296866 HerzCTKultererOCPragerMSex differences in brown adipose tissue activity and cold-induced thermogenesisMol Cell Endocrinol20215341113651:CAS:528:DC%2BB3MXhtlyqtbfO10.1016/j.mce.2021.11136534126190 ZaccardiFDhalwaniNNPapamargaritisDNonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studiesDiabetologia201760224024810.1007/s00125-016-4162-627888288 HarreiterJFadlHKautzky-WillerASimmonsDDo women with diabetes need more intensive action for cardiovascular reduction than men with diabetes?Curr Diab Rep202020116110.1007/s11892-020-01348-2330339537544714 XuGYouDWongLRisk of all-cause and CHD mortality in women versus men with type 2 diabetes: a systematic review and meta-analysisEur J Endocrinol Eur Feder Endocr Soc201918042432551:CAS:528:DC%2BC1MXlslOqtLw%3D10.1530/EJE-18-0792 OwensDRLandgrafWFrierBMCommencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: determinants of achievement of HbA1c goal less than 7.0Diabetes Obes Metab20192123213291:CAS:528:DC%2BC1MXnt1WhtQ%3D%3D10.1111/dom.13607305202176590355 CampesiIFranconiFSeghieriGMeloniMSex-gender-related therapeutic approaches for cardiovascular complications associated with diabetesPharmacol Res201711919520710.1016/j.phrs.2017.01.02328189784 GelbeneggerGPostulaMPecenLAspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroupsBMC Med20191711981:CAS:528:DC%2BC1MXitFOjsLbP10.1186/s12916-019-1428-0316795166827248 FadiniGPBonoraBMAvogaroASGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting SystemDiabetologia2017608138513891:CAS:528:DC%2BC2sXotVKms78%3D10.1007/s00125-017-4301-828500396 SuccurroEMariniMAFiorentinoTVSex-specific differences in prevalence of nonalcoholic fatty liver disease in subjects with prediabetes and type 2 diabetesDiabetes Res Clin Pract20221901100271:CAS:528:DC%2BB38Xitlartb7O10.1016/j.diabres.2022.11002735917992 HanEKimALeeSJCharacteristics of dapagliflozin responders: a longitudinal, prospective, nationwide dapagliflozin surveillance study in KoreaDiabetes Ther201894168917011:CAS:528:DC%2BC1cXhtlWnsbjK10.1007/s13300-018-0470-9299983706064582 MeyerCPimentaWWoerleHJDifferent mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humansDiabetes Care2006298190919141:CAS:528:DC%2BD28XptVKmtbk%3D10.2337/dc06-043816873801 SimonsPValkenburgOvan de WaarenburgMPHSerum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht studyDiabetologia20236612132221:CAS:528:DC%2BB38XisF2mtrnJ10.1007/s00125-022-05790-736114428 EisenbergEDi PaloKEPiñaILSex differences in heart failureClin Cardiol201841221121610.1002/clc.22917294856776489832 PerrinNEDaviesMJRobertsonNSnoekFJKhuntiKThe prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysisDiabet Med20173411150815201:STN:280:DC%2BC1cfms12nsA%3D%3D10.1111/dme.1344828799294 PongwecharakJTengmeesriNMalanusornNPanthongMPawangkapinNPrescribing metformin in type 2 diabetes with a contraindication: prevalence and outcomePharm World Sci200931448148610.1007/s11096-009-9303-219462255 JesuthasanAZhyzhneuskayaSPetersCSex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight lossDiabetologia20226512262331:CAS:528:DC%2BB38XjsFOjtbo%3D10.1007/s00125-021-05583-434657182 KarlssonTRask-AndersenMPanGContribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic diseaseNat Med2019259139013951:CAS:528:DC%2BC1MXhslelurbP10.1038/s41591-019-0563-731501611 PetrovMSTaylorRIntra-pancreatic fat deposition: bringing hidden fat to the foreNat Rev Gastroenterol Hepatol202219315316810.1038/s41575-021-00551-034880411 WalkerEAMolitchMKramerMKAdherence to preventive medications: predictors and outcomes in the Diabetes Prevention ProgramDiabetes Care20062991997200210.2337/dc06-045416936143 IndelicatoLDaurizMBacchiESex differences in the association of psychological status with measures of physical activity and sedentary behaviour in adults with type 2 diabetesActa Diabetol201855662763510.1007/s00592-018-1132-029582161 WrightAKKontopantelisEEmsleyRCardiovascular risk and risk factor management in type 2 diabetes mellitusCirculation2019139242742275310.1161/CIRCULATIONAHA.118.03910030986362 ThomGMessowCMLeslieWSPredictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT)Diabet Med2021388e143951:CAS:528:DC%2BB3MXhslWntbnN10.1111/dme.1439532870520 de RitterRSepSJSvan der KallenCJHSex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: the Maastricht studyCardiovasc Diabetol20212011021:CAS:528:DC%2BB3MXhtlegs7jP10.1186/s12933-021-01290-x339626198106227 LeutnerMMatzholdCKautzkyAMajor Depressive Disorder (MDD) and antidepressant medication are overrepresented in high-dose statin treatmentFront Med (Lausanne)2021860808310.3389/fmed.2021.60808333644093 Mauvais-JarvisFBairey MerzNBarnesPJSex and gender: modifiers of health, disease, and medicineLancet20203961025056558210.1016/S0140-6736(20)31561-0328281897440877 d'EmdenMCJenkinsAJLiLFavourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyDiabetologia20145711229623031:CAS:528:DC%2BC2cXhsVCrsb%2FL10.1007/s00125-014-3344-325149070 MutiePMPomares-MilanHAtabaki-PasdarNInvestigating the causal relationships between excess adiposity and cardiometabolic health in men and womenDiabetologia20236623213351:CAS:528:DC%2BB38Xis1OntLnI10.1007/s00125-022-05811-536221008 KimYChangYRyuSWildSHByrneCDNAFLD improves risk prediction of type 2 diabetes: with effect modification by sex and menopausal statusHepatology20227661755176510.1002/hep.3256035514152 SinghAKSinghRGender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: A systematic review and meta-analysis of cardio-vascular outcome trialsDiabetes Metab Syndr202014318118710.1016/j.dsx.2020.02.01232142999 Mauvais-JarvisFCleggDJHevenerALThe role of es A Ramezankhani (5891_CR10) 2020; 43 K Færch (5891_CR8) 2015; 64 RA Dennison (5891_CR47) 2021; 171 HD McIntyre (5891_CR46) 2019; 5 LA Eberly (5891_CR103) 2021; 4 Y Onishi (5891_CR112) 2017; 64 M Manteuffel (5891_CR95) 2014; 23 MS Petrov (5891_CR29) 2022; 19 B Gallwitz (5891_CR110) 2018; 20 AL Beale (5891_CR77) 2018; 138 Y Nakayama (5891_CR83) 2021; 68 Today Study Group (5891_CR50) 2021; 45 A Kajiwara (5891_CR90) 2016; 2016 MC d'Emden (5891_CR132) 2014; 57 J Butler (5891_CR105) 2022; 146 HF Escobar-Morreale (5891_CR41) 2018; 14 J Harreiter (5891_CR93) 2018; 9 JC Sullivan (5891_CR133) 2008; 294 A Jesuthasan (5891_CR26) 2022; 65 H Quan (5891_CR113) 2016; 30 R Retnakaran (5891_CR81) 2006; 55 AK Wright (5891_CR15) 2020; 63 A Abraham (5891_CR82) 2018; 388 International Diabetes Federation (5891_CR1) 2021 A Kautzky-Willer (5891_CR4) 2016; 37 T Zhu (5891_CR42) 2022; 107 G Wittert (5891_CR43) 2021; 9 R de Ritter (5891_CR79) 2021; 20 G Seghieri (5891_CR86) 2022; 18 M Kato (5891_CR55) 2009; 56 D Tomic (5891_CR3) 2022; 10 M Malmborg (5891_CR68) 2020; 41 DR Owens (5891_CR117) 2019; 21 KM Johnsson (5891_CR107) 2013; 27 G Xu (5891_CR84) 2019; 180 H Wu (5891_CR53) 2019; 62 PT Katzmarzyk (5891_CR18) 2013; 36 DH Lee (5891_CR21) 2018; 33 K Rådholm (5891_CR104) 2020; 22 J Fulcher (5891_CR129) 2015; 385 F Mauvais-Jarvis (5891_CR5) 2020; 396 A Kautzky-Willer (5891_CR128) 2015; 17 B Tramunt (5891_CR14) 2020; 63 D Levy (5891_CR75) 1996; 275 T Karlsson (5891_CR17) 2019; 25 DS Feig (5891_CR121) 2022; 45 M Leutner (5891_CR119) 2019; 78 J Harreiter (5891_CR44) 2020; 20 T Du (5891_CR11) 2019; 42 Y Li (5891_CR101) 2014; 37 E Chiefari (5891_CR126) 2015; 17 JC Censin (5891_CR22) 2019; 15 H Ji (5891_CR76) 2020; 5 G Yang (5891_CR34) 2022; 84 DECODE Study Group (5891_CR2) 2003; 26 F Mauvais-Jarvis (5891_CR36) 2013; 34 L Indelicato (5891_CR57) 2018; 55 P Anagnostis (5891_CR37) 2019; 180 RE Ratner (5891_CR48) 2008; 93 L Fan (5891_CR87) 2021; 16 5891_CR35 Y Kim (5891_CR12) 2022; 76 D Parizadeh (5891_CR32) 2019; 26 Y Shen (5891_CR80) 2017; 55 E Eisenberg (5891_CR134) 2018; 41 T Becher (5891_CR25) 2021; 27 J Pongwecharak (5891_CR97) 2009; 31 F Zaccardi (5891_CR19) 2017; 60 SD Solomon (5891_CR106) 2022; 387 G Ferrannini (5891_CR71) 2021; 20 KL Funck (5891_CR72) 2022; 21 Y Wang (5891_CR85) 2019; 17 SK Gandhi (5891_CR88) 2020; 169 FF Li (5891_CR118) 2018; 9 X Cai (5891_CR33) 2020; 370 VR Aroda (5891_CR99) 2015; 100 NE Perrin (5891_CR63) 2017; 34 AK Singh (5891_CR114) 2020; 14 Y Fujita (5891_CR74) 2022; 10 5891_CR61 V Raparelli (5891_CR102) 2020; 9 GH Goossens (5891_CR7) 2021; 17 R Puri (5891_CR130) 2014; 7 CT Herz (5891_CR24) 2021; 534 A Kautzky-Willer (5891_CR51) 2012; 12 EA Walker (5891_CR96) 2006; 29 LA Rivera (5891_CR52) 2015; 14 MJ Wensink (5891_CR122) 2022; 175 A Kautzky-Willer (5891_CR9) 2021; 185 AK Eriksson (5891_CR56) 2013; 36 Prospective Studies Collaboration, Asia Pacific Cohort Studies Collaboration (5891_CR65) 2018; 6 JM Dennis (5891_CR100) 2018; 41 A Kautzky-Willer (5891_CR27) 2003; 52 A Kajiwara (5891_CR92) 2014; 103 S Ramachandran (5891_CR39) 2019; 7 GP Fadini (5891_CR108) 2017; 60 E Gerdts (5891_CR78) 2019; 25 K-I Joung (5891_CR127) 2020; 10 ML Aaberg (5891_CR91) 2008; 22 KK Clemens (5891_CR70) 2020; 43 PM Mutie (5891_CR23) 2023; 66 W Xu (5891_CR38) 2019; 240 AK Wright (5891_CR66) 2019; 139 G Hu (5891_CR69) 2003; 46 R Anichini (5891_CR111) 2013; 6 Z Zhou (5891_CR109) 2019; 62 C Meyer (5891_CR31) 2006; 29 SD Solomon (5891_CR137) 2019; 381 I Campesi (5891_CR123) 2017; 119 MW Nielsen (5891_CR6) 2021; 12 L Yuen (5891_CR45) 2018; 18 C Anderwald (5891_CR30) 2011; 96 HR Murphy (5891_CR49) 2022; 45 T Ohkuma (5891_CR73) 2019; 62 G Thom (5891_CR94) 2021; 38 A Kautzky-Willer (5891_CR62) 2017; 131 JC Link (5891_CR20) 2020; 130 PM Ridker (5891_CR135) 2005; 352 Y Gao (5891_CR59) 2020; 37 E D'Andrea (5891_CR115) 2020; 19 A de Hauteclocque (5891_CR89) 2014; 31 SJ Bersoff-Matcha (5891_CR125) 2019; 170 K Esposito (5891_CR116) 2015; 5 P Simons (5891_CR40) 2023; 66 R Huxley (5891_CR64) 2006; 332 E Han (5891_CR124) 2018; 9 G Gelbenegger (5891_CR136) 2019; 17 M Schütt (5891_CR98) 2015; 123 P King (5891_CR131) 2018; 71 A Silva-Costa (5891_CR58) 2020; 37 R Rubin (5891_CR16) 2018; 319 TM Peters (5891_CR67) 2021; 44 A Kautzky-Willer (5891_CR60) 2017; 281 M Leutner (5891_CR120) 2021; 8 JJV McMurray (5891_CR138) 2020; 141 M Leutner (5891_CR28) 2018; 2018 E Succurro (5891_CR13) 2022; 190 The Lancet Diabetes Endocrinology (5891_CR54) 2017; 5 37042956 - Diabetologia. 2023 Jun;66(6):1165. doi: 10.1007/s00125-023-05913-8. |
| References_xml | – reference: ClemensKKWoodwardMNealBZinmanBSex disparities in cardiovascular outcome trials of populations with diabetes: a systematic review and meta-analysisDiabetes Care20204351157116310.2337/dc19-225732312859 – reference: ZhouZJardineMPerkovicVCanagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS ProgramDiabetologia20196210185418671:CAS:528:DC%2BC1MXhsFOqurbN10.1007/s00125-019-4955-5313998456731200 – reference: EspositoKChiodiniPMaiorinoMIA nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patientsBMJ Open201552e00589210.1136/bmjopen-2014-005892256878974336462 – reference: SinghAKSinghRGender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: A systematic review and meta-analysis of cardio-vascular outcome trialsDiabetes Metab Syndr202014318118710.1016/j.dsx.2020.02.01232142999 – reference: WrightAKKontopantelisEEmsleyRCardiovascular risk and risk factor management in type 2 diabetes mellitusCirculation2019139242742275310.1161/CIRCULATIONAHA.118.03910030986362 – reference: AbrahamABarnettCKatzbergHDLovblomLEPerkinsBABrilVSex differences in neuropathic pain intensity in diabetesJ Neurol Sci201838810310610.1016/j.jns.2018.03.00829627001 – reference: DennisJMHenleyWEWeedonMNSex and BMI alter the benefits and risks of sulfonylureas and thiazolidinediones in type 2 diabetes: a framework for evaluating stratification using routine clinical and individual trial dataDiabetes Care20184191844185310.2337/dc18-034430072404 – reference: OnishiYOuraTMatsuiAMatsuuraJIwamotoNAnalysis of efficacy and safety of dulaglutide 0.75 mg stratified by sex in patients with type 2 diabetes in 2 randomized, controlled phase 3 studies in JapanEndocr J20176455535601:CAS:528:DC%2BC1MXotlygsg%3D%3D10.1507/endocrj.EJ16-055228367916 – reference: SullivanJCSex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibitionAm J Physiol Regul Integr Comp Physiol20082944R1220R12261:CAS:528:DC%2BD1cXkvVyksLg%3D10.1152/ajpregu.00864.200718287217 – reference: GerdtsERegitz-ZagrosekVSex differences in cardiometabolic disordersNat Med20192511165716661:CAS:528:DC%2BC1MXitFaktLfF10.1038/s41591-019-0643-831700185 – reference: MeyerCPimentaWWoerleHJDifferent mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humansDiabetes Care2006298190919141:CAS:528:DC%2BD28XptVKmtbk%3D10.2337/dc06-043816873801 – reference: Today Study GroupPregnancy outcomes in young women with youth-onset type 2 diabetes followed in the TODAY studyDiabetes Care2021455103810451:CAS:528:DC%2BB38XhsFyqt7%2FO10.2337/dc21-10719174960 – reference: HerzCTKultererOCPragerMSex differences in brown adipose tissue activity and cold-induced thermogenesisMol Cell Endocrinol20215341113651:CAS:528:DC%2BB3MXhtlyqtbfO10.1016/j.mce.2021.11136534126190 – reference: PetrovMSTaylorRIntra-pancreatic fat deposition: bringing hidden fat to the foreNat Rev Gastroenterol Hepatol202219315316810.1038/s41575-021-00551-034880411 – reference: RiveraLALebenbaumMRosellaLCThe influence of socioeconomic status on future risk for developing Type 2 diabetes in the Canadian population between 2011 and 2022: differential associations by sexInt J Equity Health20151410110.1186/s12939-015-0245-0264967684619358 – reference: PuriRNissenSEShaoMSex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURNJACC Cardiovasc Imaging20147101013102210.1016/j.jcmg.2014.04.01925240453 – reference: ErikssonAKvan den DonkMHildingAOstensonCGWork stress, sense of coherence, and risk of type 2 diabetes in a prospective study of middle-aged Swedish men and womenDiabetes Care20133692683268910.2337/dc12-1738236373563747928 – reference: JoungK-IJungG-WParkH-HLeeHParkS-HShinJ-YGender differences in adverse event reports associated with antidiabetic drugsSci Rep2020101175451:CAS:528:DC%2BB3cXitFCks77F10.1038/s41598-020-74000-4330675197567832 – reference: NakayamaYYamaguchiSShinzatoYRetrospective exploratory analyses on gender differences in determinants for incidence and progression of diabetic retinopathy in Japanese patients with type 2 diabetes mellitusEndocr J20216866556691:CAS:528:DC%2BB3MXhvVeqs73E10.1507/endocrj.EJ20-063033551433 – reference: XuWMorfordJMauvais-JarvisFEmerging role of testosterone in pancreatic beta-cell function and insulin secretionJ Endocrinol20192403R97R1051:CAS:528:DC%2BC1MXotFKjsLk%3D10.1530/JOE-18-0573 – reference: KajiwaraAKitaASaruwatariJSex differences in the renal function decline of patients with type 2 diabetesJ Diabetes Res2016201646263821:CAS:528:DC%2BC1cXmsFSiu7Y%3D10.1155/2016/4626382272479484876234 – reference: FeigDSZinmanBAsztalosEDeterminants of small for gestational age in women with type 2 diabetes in pregnancy: who should receive metformin?Diabetes Care2022457153215391:CAS:528:DC%2BB38XitFGgsrvE10.2337/dc22-001335671033 – reference: Bersoff-MatchaSJChamberlainCCaoCKortepeterCChongWHFournier gangrene associated with sodium-glucose cotransporter-2 inhibitors: a review of spontaneous postmarketing casesAnn Intern Med20191701176476910.7326/M19-008531060053 – reference: SeghieriGPolicardoLGualdaniEFrancesconiPGender differences in the risk of adverse outcomes after incident diabetic foot hospitalization: a population cohort studyCurr Diabetes Rev2022186e27082119590410.2174/157339981766621082712193734455962 – reference: ChiefariECapulaCVeroAAdd-on treatment with liraglutide improves glycemic control in patients with type 2 diabetes on metformin therapyDiabetes Technol Ther20151774684741:CAS:528:DC%2BC2MXhtV2murnF10.1089/dia.2014.041225844858 – reference: KimYChangYRyuSWildSHByrneCDNAFLD improves risk prediction of type 2 diabetes: with effect modification by sex and menopausal statusHepatology20227661755176510.1002/hep.3256035514152 – reference: PetersTMHolmesMVRichardsJBSex differences in the risk of coronary heart disease associated with type 2 diabetes: a mendelian randomization analysisDiabetes Care20214425565621:CAS:528:DC%2BB3MXnslygsLs%3D10.2337/dc20-113733277303 – reference: FujitaYMorimotoTTokushigeAWomen with type 2 diabetes and coronary artery disease have a higher risk of heart failure than men, with a significant gender interaction between heart failure risk and risk factor management: a retrospective registry studyBMJ Open Diabetes Res Care2022102e00270710.1136/bmjdrc-2021-002707354738269045107 – reference: DennisonRAChenESGreenMEThe absolute and relative risk of type 2 diabetes after gestational diabetes: A systematic review and meta-analysis of 129 studiesDiabetes Res Clin Pract202117110862510.1016/j.diabres.2020.10862533333204 – reference: WittertGBrackenKRobledoKPTestosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trialLancet Diabetes Endocrinol20219132451:CAS:528:DC%2BB3MXit12rurg%3D10.1016/S2213-8587(20)30367-333338415 – reference: The Lancet Diabetes EndocrinologySex disparities in diabetes: bridging the gapLancet Diabetes Endocrinol20175118391:STN:280:DC%2BC1M7lslKrsQ%3D%3D10.1016/S2213-8587(17)30336-429082880 – reference: LeeDHKeumNHuFBComparison of the association of predicted fat mass, body mass index, and other obesity indicators with type 2 diabetes risk: two large prospective studies in US men and womenEur J Epidemiol20183311111311231:CAS:528:DC%2BC1cXhsFaru7zN10.1007/s10654-018-0433-530117031 – reference: TramuntBSmatiSGrandgeorgeNSex differences in metabolic regulation and diabetes susceptibilityDiabetologia202063345346110.1007/s00125-019-05040-331754750 – reference: FærchKTorekovSSVistisenDGLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO studyDiabetes2015647251325251:CAS:528:DC%2BC2MXhtFynsr7F10.2337/db14-175125677912 – reference: BealeALMeyerPMarwickTHLamCSPKayeDMSex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fractionCirculation2018138219820510.1161/CIRCULATIONAHA.118.03427129986961 – reference: McMurrayJJVJacksonAMLamCSPEffects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HFCirculation2020141533835110.1161/CIRCULATIONAHA.119.04449131736337 – reference: Kautzky-WillerAHarreiterJSex and gender differences in therapy of type 2 diabetesDiabetes Res Clin Pract20171312302411:CAS:528:DC%2BC2sXhtFyit7zI10.1016/j.diabres.2017.07.01228779681 – reference: MalmborgMSchmiegelowMDSNorgaardCHDoes type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?Eur Heart J202041131346135310.1093/eurheartj/ehz91331860067 – reference: SchüttMZimmermannAHoodRGender-specific effects of treatment with lifestyle, metformin or sulfonylurea on glycemic control and body weight: a german multicenter analysis on 9 108 patientsExp Clin Endocrinol Diabetes2015123106226261:CAS:528:DC%2BC2MXhtlKntL%2FP10.1055/s-0035-155960826285070 – reference: JohnssonKMPtaszynskaASchmitzBSuggJParikhSJListJFVulvovaginitis and balanitis in patients with diabetes treated with dapagliflozinJ Diabetes Complicat201327547948410.1016/j.jdiacomp.2013.04.012 – reference: CaiXZhangYLiMAssociation between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysisBMJ2020370m229710.1136/bmj.m2297326692827362233 – reference: LeutnerMMatzholdCKautzkyAMajor Depressive Disorder (MDD) and antidepressant medication are overrepresented in high-dose statin treatmentFront Med (Lausanne)2021860808310.3389/fmed.2021.60808333644093 – reference: AnagnostisPChristouKArtzouchaltziAMEarly menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysisEur J Endocrinol2019180141501:CAS:528:DC%2BC1MXjtlKqsbY%3D10.1530/EJE-18-060230400047 – reference: FanLWuXJSex difference for the risk of amputation in diabetic patients: a systematic review and meta-analysisPLoS One2021163e02437971:CAS:528:DC%2BB3MXntVWrtL4%3D10.1371/journal.pone.0243797337054307951841 – reference: HarreiterJKautzky-WillerASex and gender differences in prevention of type 2 diabetesFront Endocrinol (Lausanne)2018922010.3389/fendo.2018.0022029780358 – reference: EberlyLAYangLEneanyaNDAssociation of race/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the USJAMA Netw Open202144e21613910.1001/jamanetworkopen.2021.6139338564758050743 – reference: HarreiterJFadlHKautzky-WillerASimmonsDDo women with diabetes need more intensive action for cardiovascular reduction than men with diabetes?Curr Diab Rep202020116110.1007/s11892-020-01348-2330339537544714 – reference: OhkumaTKomoritaYPetersSAEWoodwardMDiabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individualsDiabetologia20196291550156010.1007/s00125-019-4926-x313172306677875 – reference: FadiniGPBonoraBMAvogaroASGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting SystemDiabetologia2017608138513891:CAS:528:DC%2BC2sXotVKms78%3D10.1007/s00125-017-4301-828500396 – reference: SimonsPValkenburgOvan de WaarenburgMPHSerum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht studyDiabetologia20236612132221:CAS:528:DC%2BB38XisF2mtrnJ10.1007/s00125-022-05790-736114428 – reference: ArodaVRChristophiCAEdelsteinSLThe effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-upJ Clin Endocrinol Metab20151004164616531:CAS:528:DC%2BC2MXmsFaitrk%3D10.1210/jc.2014-3761257062404399293 – reference: ZhuTGoodarziMOCauses and consequences of polycystic ovary syndrome: insights from mendelian randomizationJ Clin Endocrinol Metab20221073e899e91110.1210/clinem/dgab75734669940 – reference: OwensDRLandgrafWFrierBMCommencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: determinants of achievement of HbA1c goal less than 7.0Diabetes Obes Metab20192123213291:CAS:528:DC%2BC1MXnt1WhtQ%3D%3D10.1111/dom.13607305202176590355 – reference: d'EmdenMCJenkinsAJLiLFavourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyDiabetologia20145711229623031:CAS:528:DC%2BC2cXhsVCrsb%2FL10.1007/s00125-014-3344-325149070 – reference: YangGAu YeungSLSchoolingCMSex differences in the association of fasting glucose with HbA1c, and their consequences for mortality: A Mendelian randomization studyEBioMedicine2022841042591:CAS:528:DC%2BB38Xis1ajtr7I10.1016/j.ebiom.2022.104259361795529520189 – reference: Kautzky-WillerAThurnerSKlimekPUse of statins offsets insulin-related cancer riskJ Intern Med201728122062161:CAS:528:DC%2BC2sXhtlWqurw%3D10.1111/joim.1256727766700 – reference: AnderwaldCGastaldelliATuraAMechanism and effects of glucose absorption during an oral glucose tolerance test among females and malesJ Clin Endocrinol Metab20119625155241:CAS:528:DC%2BC3MXisVOmsb0%3D10.1210/jc.2010-139821147888 – reference: FerranniniGDe BacquerDVynckierPGender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveysCardiovasc Diabetol2021201381:CAS:528:DC%2BB3MXmsFGgsb8%3D10.1186/s12933-021-01233-6335736657879645 – reference: SolomonSDMcMurrayJJVClaggettBDapagliflozin in heart failure with mildly reduced or preserved ejection fractionN Engl J Med2022387121089109810.1056/NEJMoa220628636027570 – reference: de HauteclocqueARagotSSlaouiYThe influence of sex on renal function decline in people with Type 2 diabetesDiabet Med2014319112111281:CAS:528:DC%2BC2cXhsVSrurrK10.1111/dme.1247824773061 – reference: HuGDecode Study GroupGender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetesDiabetologia20034656086171:STN:280:DC%2BD3s3ot12ltQ%3D%3D10.1007/s00125-003-1096-612750769 – reference: WalkerEAMolitchMKramerMKAdherence to preventive medications: predictors and outcomes in the Diabetes Prevention ProgramDiabetes Care20062991997200210.2337/dc06-045416936143 – reference: WensinkMJLuYTianLPreconception antidiabetic drugs in men and birth defects in offspring : a nationwide cohort studyAnn Intern Med2022175566567310.7326/M21-4389353443809844982 – reference: ShenYCaiRSunJDiabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysisEndocrine201755166761:CAS:528:DC%2BC28Xht1KrtrbP10.1007/s12020-016-1014-627477292 – reference: RetnakaranRCullCAThorneKIAdlerAIHolmanRRGroup USRisk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74Diabetes2006556183218391:CAS:528:DC%2BD28Xlsl2gu7w%3D10.2337/db05-162016731850 – reference: RidkerPMCookNRLeeIMA randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in womenN Engl J Med200535213129313041:CAS:528:DC%2BD2MXislCjs7Y%3D10.1056/NEJMoa05061315753114 – reference: IndelicatoLDaurizMBacchiESex differences in the association of psychological status with measures of physical activity and sedentary behaviour in adults with type 2 diabetesActa Diabetol201855662763510.1007/s00592-018-1132-029582161 – reference: EisenbergEDi PaloKEPiñaILSex differences in heart failureClin Cardiol201841221121610.1002/clc.22917294856776489832 – reference: Deischinger C, Dervic E, Leutner M et al (2020) Diabetes mellitus is associated with a higher risk for major depressive disorder in women than in men. BMJ Open Diabetes Res Care 8(1). https://doi.org/10.1136/bmjdrc-2020-001430 – reference: QuanHZhangHWeiWFangTGender-related different effects of a combined therapy of Exenatide and Metformin on overweight or obesity patients with type 2 diabetes mellitusJ Diabetes Complications201630468669210.1016/j.jdiacomp.2016.01.01326873871 – reference: GoossensGHJockenJWEBlaakEESexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liverNat Rev Endocrinol2021171476610.1038/s41574-020-00431-833173188 – reference: YuenLWongVWSimmonsDEthnic disparities in gestational diabetesCurr Diab Rep2018189681:CAS:528:DC%2BC1cXhtlOis7vK10.1007/s11892-018-1040-230039471 – reference: HanEKimALeeSJCharacteristics of dapagliflozin responders: a longitudinal, prospective, nationwide dapagliflozin surveillance study in KoreaDiabetes Ther201894168917011:CAS:528:DC%2BC1cXhtlWnsbjK10.1007/s13300-018-0470-9299983706064582 – reference: American Diabetes Association Professional Practice Committee (2022) 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2022. Diabetes Care 45(Suppl 1):S46–S59. https://doi.org/10.2337/dc22-S004 – reference: MutiePMPomares-MilanHAtabaki-PasdarNInvestigating the causal relationships between excess adiposity and cardiometabolic health in men and womenDiabetologia20236623213351:CAS:528:DC%2BB38Xis1OntLnI10.1007/s00125-022-05811-536221008 – reference: TomicDMortonJIChenLLifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based studyLancet Diabetes Endocrinol2022101179580310.1016/S2213-8587(22)00252-236183736 – reference: AabergMLBurchDMHudZRZachariasMPGender differences in the onset of diabetic neuropathyJ Diabetes Complications2008222838710.1016/j.jdiacomp.2007.06.00918280437 – reference: SuccurroEMariniMAFiorentinoTVSex-specific differences in prevalence of nonalcoholic fatty liver disease in subjects with prediabetes and type 2 diabetesDiabetes Res Clin Pract20221901100271:CAS:528:DC%2BB38Xitlartb7O10.1016/j.diabres.2022.11002735917992 – reference: KajiwaraAMiyagawaHSaruwatariJGender differences in the incidence and progression of diabetic retinopathy among Japanese patients with type 2 diabetes mellitus: a clinic-based retrospective longitudinal studyDiabetes Res Clin Pract20141033e7101:STN:280:DC%2BC2cvislCjtw%3D%3D10.1016/j.diabres.2013.12.04324503044 – reference: RamezankhaniAAziziFHadaeghFSex differences in rates of change and burden of metabolic risk factors among adults who did and did not go on to develop diabetes: two decades of follow-up from the tehran lipid and glucose studyDiabetes Care202043123061306910.2337/dc20-111233020051 – reference: Kautzky-WillerAHarreiterJPaciniGSex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitusEndocr Rev20163732783161:CAS:528:DC%2BC1cXkt1Oqs7w%3D10.1210/er.2015-1137271598754890267 – reference: RådholmKZhouZClemensKNealBWoodwardMEffects of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes in women versus menDiabetes, Obes Metab20202222632661:CAS:528:DC%2BB3cXht1Oisbg%3D10.1111/dom.1387631486272 – reference: Kautzky-WillerADornerTJensbyARiederAWomen show a closer association between educational level and hypertension or diabetes mellitus than males: a secondary analysis from the Austrian HISBMC Public Health20121239210.1186/1471-2458-12-392226460953407471 – reference: LeutnerMGoblCWolfPPericardial fat relates to disturbances of glucose metabolism in women with the polycystic ovary syndrome, but not in healthy control subjectsInt J Endocrinol2018201854061281:CAS:528:DC%2BC1MXhslahsbfM10.1155/2018/5406128301589746109482 – reference: LiFFZhangYZhangWLMale patients with longstanding type 2 diabetes have a higher incidence of hypoglycemia compared with female patientsDiabetes Ther201895196919771:CAS:528:DC%2BC1cXhsFOjsrvE10.1007/s13300-018-0492-3301360746167277 – reference: KatoMNodaMInoueMKadowakiTTsuganeSPsychological factors, coffee and risk of diabetes mellitus among middle-aged Japanese: a population-based prospective study in the JPHC study cohortEndocr J200956345946810.1507/endocrj.k09e-00319270421 – reference: McIntyreHDCatalanoPZhangCDesoyeGMathiesenERDammPGestational diabetes mellitusNat Rev Dis Primers2019514710.1038/s41572-019-0098-831296866 – reference: KarlssonTRask-AndersenMPanGContribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic diseaseNat Med2019259139013951:CAS:528:DC%2BC1MXhslelurbP10.1038/s41591-019-0563-731501611 – reference: HuxleyRBarziFWoodwardMExcess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studiesBMJ20063327533737810.1136/bmj.38678.389583.7C163714031326926 – reference: MurphyHRMosesRGPregnancy outcomes of young women with type 2 diabetes: poor care and inadequate attention to glycemiaDiabetes Care20224551046104810.2337/dci21-005935561136 – reference: GaoYGanTJiangLAssociation between shift work and risk of type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of observational studiesChronobiol Int2020371294610.1080/07420528.2019.168357031684766 – reference: SolomonSDMcMurrayJJVAnandISAngiotensin-neprilysin inhibition in heart failure with preserved ejection fractionN Engl J Med201938117160916201:CAS:528:DC%2BC1MXitFWkt73L10.1056/NEJMoa190865531475794 – reference: LeutnerMMatzholdCBellachLDiagnosis of osteoporosis in statin-treated patients is dose-dependentAnn Rheum Dis20197812170617111:CAS:528:DC%2BB3cXhtVSrs7bJ10.1136/annrheumdis-2019-21571431558481 – reference: LinkJCWieseCBChenXX chromosome dosage of histone demethylase KDM5C determines sex differences in adiposityJ Clin Invest202013011568857021:CAS:528:DC%2BB3cXitlSnt7%2FN10.1172/JCI140223327015097598065 – reference: GelbeneggerGPostulaMPecenLAspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroupsBMC Med20191711981:CAS:528:DC%2BC1MXitFOjsLbP10.1186/s12916-019-1428-0316795166827248 – reference: PongwecharakJTengmeesriNMalanusornNPanthongMPawangkapinNPrescribing metformin in type 2 diabetes with a contraindication: prevalence and outcomePharm World Sci200931448148610.1007/s11096-009-9303-219462255 – reference: FulcherJO'ConnellRVoyseyMEfficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trialsLancet20153859976139714051:CAS:528:DC%2BC2MXovVemtQ%3D%3D10.1016/S0140-6736(14)61368-425579834 – reference: WrightAKWelshPGillJMRAge-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetesDiabetologia2020638154215531:CAS:528:DC%2BB3cXpvVanur0%3D10.1007/s00125-020-05169-6324358217351865 – reference: JesuthasanAZhyzhneuskayaSPetersCSex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight lossDiabetologia20226512262331:CAS:528:DC%2BB38XjsFOjtbo%3D10.1007/s00125-021-05583-434657182 – reference: RaparelliVElharramMMouraCSSex differences in cardiovascular effectiveness of newer glucose-lowering drugs added to metformin in type 2 diabetes mellitusJ Am Heart Assoc202091e0129401:CAS:528:DC%2BB3cXht1Kqt7%2FE10.1161/JAHA.119.012940319023266988160 – reference: de RitterRSepSJSvan der KallenCJHSex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: the Maastricht studyCardiovasc Diabetol20212011021:CAS:528:DC%2BB3MXhtlegs7jP10.1186/s12933-021-01290-x339626198106227 – reference: FunckKLBjergLIsaksenAASandbaekAGroveELGender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a Danish nationwide cohort studyCardiovasc Diabetol20222112791:CAS:528:DC%2BB38XjtFSmtbvL10.1186/s12933-022-01713-3364964029737743 – reference: ManteuffelMWilliamsSChenWVerbruggeRRPittmanDGSteinkellnerAInfluence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelinesJ Womens Health (Larchmt)201423211211910.1089/jwh.2012.397224206025 – reference: GallwitzBDagogo-JackSThieuVEffect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1cDiabetes Obes Metab20182024094181:CAS:528:DC%2BC1cXhsVaktrk%3D10.1111/dom.1308628817231 – reference: PerrinNEDaviesMJRobertsonNSnoekFJKhuntiKThe prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysisDiabet Med20173411150815201:STN:280:DC%2BC1cfms12nsA%3D%3D10.1111/dme.1344828799294 – reference: ParizadehDRahimianNAkbarpourSAziziFHadaeghFSex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose StudyEur J Prev Cardiol201926101080109110.1177/204748731983439630862232 – reference: WuHBraggFYangLSex differences in the association between socioeconomic status and diabetes prevalence and incidence in China: cross-sectional and prospective studies of 0.5 million adultsDiabetologia20196281420142910.1007/s00125-019-4896-z311521866647183 – reference: DECODE Study GroupAge- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohortsDiabetes Care2003261616910.2337/diacare.26.1.61 – reference: LiYHuYLeySHRajpathakSHuFBSulfonylurea use and incident cardiovascular disease among patients with type 2 diabetes: prospective cohort study among womenDiabetes Care20143711310631131:CAS:528:DC%2BC2cXitVWlur%2FM10.2337/dc14-1306251501574207206 – reference: CensinJCPetersSAEBovijnJCausal relationships between obesity and the leading causes of death in women and menPLoS Genet20191510e10084051:CAS:528:DC%2BC1MXisVahurvF10.1371/journal.pgen.1008405316478086812754 – reference: XuGYouDWongLRisk of all-cause and CHD mortality in women versus men with type 2 diabetes: a systematic review and meta-analysisEur J Endocrinol Eur Feder Endocr Soc201918042432551:CAS:528:DC%2BC1MXlslOqtLw%3D10.1530/EJE-18-0792 – reference: NielsenMWStefanickMLPeragineDGender-related variables for health researchBiol Sex Differ20211212310.1186/s13293-021-00366-3336187697898259 – reference: CampesiIFranconiFSeghieriGMeloniMSex-gender-related therapeutic approaches for cardiovascular complications associated with diabetesPharmacol Res201711919520710.1016/j.phrs.2017.01.02328189784 – reference: ThomGMessowCMLeslieWSPredictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT)Diabet Med2021388e143951:CAS:528:DC%2BB3MXhslWntbnN10.1111/dme.1439532870520 – reference: DuTFernandezCBarshopRSex differences in cardiovascular risk profile from childhood to midlife between individuals who did and did not develop diabetes at follow-up: the bogalusa heart studyDiabetes Care201942463564310.2337/dc18-2029306922386429632 – reference: JiHKimAEbingerJESex differences in blood pressure trajectories over the life courseJAMA Cardiol202053192610.1001/jamacardio.2019.5306319400106990675 – reference: Kautzky-WillerAKrssakMWinzerCIncreased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetesDiabetes20035222442511:CAS:528:DC%2BD3sXhtFagu7o%3D10.2337/diabetes.52.2.24412540593 – reference: Escobar-MorrealeHFPolycystic ovary syndrome: definition, aetiology, diagnosis and treatmentNat Rev Endocrinol201814527028410.1038/nrendo.2018.2429569621 – reference: RatnerREChristophiCAMetzgerBEPrevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventionsJ Clin Endocrinol Metab20089312477447791:CAS:528:DC%2BD1cXhsVyqtbvO10.1210/jc.2008-0772188269992626441 – reference: BecherTPalanisamySKramerDJBrown adipose tissue is associated with cardiometabolic healthNat Med202127158651:CAS:528:DC%2BB3MXksleltw%3D%3D10.1038/s41591-020-1126-7333981608461455 – reference: LevyDLarsonMGVasanRSKannelWBHoKKThe progression from hypertension to congestive heart failureJAMA199627520155715621:STN:280:DyaK283htlyquw%3D%3D10.1001/jama.1996.035304400370348622246 – reference: Silva-CostaARotenbergLToivanenSLifetime night work exposure and the risk of type 2 diabetes: results from the longitudinal study of adult health (ELSA-Brasil)Chronobiol Int2020379-101344134710.1080/07420528.2020.180492333003956 – reference: Prospective Studies Collaboration, Asia Pacific Cohort Studies CollaborationSex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studiesLancet Diabetes Endocrinol20186753854610.1016/S2213-8587(18)30079-2 – reference: KatzmarzykPTHuGCefaluWTMireEBouchardCThe importance of waist circumference and BMI for mortality risk in diabetic adultsDiabetes Care201336103128313010.2337/dc13-0219237574293781507 – reference: Kautzky-WillerAKosiLLinJMihaljevicRGender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trialsDiabetes, Obes Metab20151765335401:CAS:528:DC%2BC2MXntFGgsLs%3D10.1111/dom.1244925678212 – reference: International Diabetes FederationIDF Diabetes Atlas202110BrusselsInternational Diabetes Federation – reference: RamachandranSHackettGIStrangeRCSex hormone binding globulin: a review of its interactions with testosterone and age, and its impact on mortality in men with type 2 diabetesSex Med Rev20197466967810.1016/j.sxmr.2019.06.00631447413 – reference: RubinRPostmenopausal women with a "Normal" BMI might be overweight or even obeseJAMA2018319121185118710.1001/jama.2018.042329516084 – reference: ZaccardiFDhalwaniNNPapamargaritisDNonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studiesDiabetologia201760224024810.1007/s00125-016-4162-627888288 – reference: GandhiSKWaschbuschMMichaelMAge- and sex-specific incidence of non-traumatic lower limb amputation in patients with type 2 diabetes mellitus in a U.S. claims databaseDiabetes Res Clin Pract202016910845210.1016/j.diabres.2020.10845232949656 – reference: AnichiniRCosimiSDi CarloAGender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experienceDiabetes Metab Syndr Obes201361231291:CAS:528:DC%2BC3sXosVSnurw%3D10.2147/dmso.S42729236304273626369 – reference: KingPPuriRBallantyneCSex-related difference in the regression of coronary atherosclerosis with the PCSK9 inhibitor, evolocumab: insights from GLAGOVJ Am Coll Cardiol20187111_SupplementA1077A107710.1016/S0735-1097(18)31618-8 – reference: Kautzky-WillerADoes diabetes mellitus mitigate the gender gap in COVID-19 mortality?Eur J Endocrinol20211855C13C171:CAS:528:DC%2BB3MXit12rsbzI10.1530/EJE-21-0721345163928558844 – reference: Mauvais-JarvisFBairey MerzNBarnesPJSex and gender: modifiers of health, disease, and medicineLancet20203961025056558210.1016/S0140-6736(20)31561-0328281897440877 – reference: Mauvais-JarvisFCleggDJHevenerALThe role of estrogens in control of energy balance and glucose homeostasisEndocr Rev20133433093381:CAS:528:DC%2BC3sXpvVOmt7c%3D10.1210/er.2012-1055234607193660717 – reference: D'AndreaEKesselheimASFranklinJMJungEHHeySPPatornoEHeterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysisCardiovasc Diabetol20201911541:CAS:528:DC%2BB3cXitVagsr3J10.1186/s12933-020-01133-1329936547525990 – reference: ButlerJFilippatosGSiddiqiTJEffects of empagliflozin in women and men with heart failure and preserved ejection fractionCirculation202214614104610551:CAS:528:DC%2BB38XivVart7%2FM10.1161/CIRCULATIONAHA.122.059755360980519528945 – reference: WangYO'NeilAJiaoYSex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participantsBMC Med20191711361:CAS:528:DC%2BC1MXhtlGrsrfL10.1186/s12916-019-1355-0312962056625042 – volume: 123 start-page: 622 issue: 10 year: 2015 ident: 5891_CR98 publication-title: Exp Clin Endocrinol Diabetes doi: 10.1055/s-0035-1559608 – volume: 281 start-page: 206 issue: 2 year: 2017 ident: 5891_CR60 publication-title: J Intern Med doi: 10.1111/joim.12567 – volume: 44 start-page: 556 issue: 2 year: 2021 ident: 5891_CR67 publication-title: Diabetes Care doi: 10.2337/dc20-1137 – volume: 23 start-page: 112 issue: 2 year: 2014 ident: 5891_CR95 publication-title: J Womens Health (Larchmt) doi: 10.1089/jwh.2012.3972 – volume: 45 start-page: 1046 issue: 5 year: 2022 ident: 5891_CR49 publication-title: Diabetes Care doi: 10.2337/dci21-0059 – volume: 45 start-page: 1532 issue: 7 year: 2022 ident: 5891_CR121 publication-title: Diabetes Care doi: 10.2337/dc22-0013 – volume: 21 start-page: 321 issue: 2 year: 2019 ident: 5891_CR117 publication-title: Diabetes Obes Metab doi: 10.1111/dom.13607 – volume: 20 start-page: 61 issue: 11 year: 2020 ident: 5891_CR44 publication-title: Curr Diab Rep doi: 10.1007/s11892-020-01348-2 – volume: 18 start-page: 68 issue: 9 year: 2018 ident: 5891_CR45 publication-title: Curr Diab Rep doi: 10.1007/s11892-018-1040-2 – volume: 20 start-page: 38 issue: 1 year: 2021 ident: 5891_CR71 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-021-01233-6 – volume: 5 start-page: e005892 issue: 2 year: 2015 ident: 5891_CR116 publication-title: BMJ Open doi: 10.1136/bmjopen-2014-005892 – volume: 10 start-page: e002707 issue: 2 year: 2022 ident: 5891_CR74 publication-title: BMJ Open Diabetes Res Care doi: 10.1136/bmjdrc-2021-002707 – volume: 57 start-page: 2296 issue: 11 year: 2014 ident: 5891_CR132 publication-title: Diabetologia doi: 10.1007/s00125-014-3344-3 – volume: 64 start-page: 2513 issue: 7 year: 2015 ident: 5891_CR8 publication-title: Diabetes doi: 10.2337/db14-1751 – volume: 43 start-page: 3061 issue: 12 year: 2020 ident: 5891_CR10 publication-title: Diabetes Care doi: 10.2337/dc20-1112 – ident: 5891_CR61 doi: 10.1136/bmjdrc-2020-001430 – volume: 63 start-page: 1542 issue: 8 year: 2020 ident: 5891_CR15 publication-title: Diabetologia doi: 10.1007/s00125-020-05169-6 – volume: 180 start-page: 243 issue: 4 year: 2019 ident: 5891_CR84 publication-title: Eur J Endocrinol Eur Feder Endocr Soc doi: 10.1530/EJE-18-0792 – volume: 41 start-page: 1844 issue: 9 year: 2018 ident: 5891_CR100 publication-title: Diabetes Care doi: 10.2337/dc18-0344 – volume: 56 start-page: 459 issue: 3 year: 2009 ident: 5891_CR55 publication-title: Endocr J doi: 10.1507/endocrj.k09e-003 – volume: 25 start-page: 1390 issue: 9 year: 2019 ident: 5891_CR17 publication-title: Nat Med doi: 10.1038/s41591-019-0563-7 – volume: 31 start-page: 481 issue: 4 year: 2009 ident: 5891_CR97 publication-title: Pharm World Sci doi: 10.1007/s11096-009-9303-2 – volume: 352 start-page: 1293 issue: 13 year: 2005 ident: 5891_CR135 publication-title: N Engl J Med doi: 10.1056/NEJMoa050613 – volume: 20 start-page: 102 issue: 1 year: 2021 ident: 5891_CR79 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-021-01290-x – volume: 76 start-page: 1755 issue: 6 year: 2022 ident: 5891_CR12 publication-title: Hepatology doi: 10.1002/hep.32560 – volume: 2016 start-page: 4626382 year: 2016 ident: 5891_CR90 publication-title: J Diabetes Res doi: 10.1155/2016/4626382 – volume: 15 start-page: e1008405 issue: 10 year: 2019 ident: 5891_CR22 publication-title: PLoS Genet doi: 10.1371/journal.pgen.1008405 – volume: 185 start-page: C13 issue: 5 year: 2021 ident: 5891_CR9 publication-title: Eur J Endocrinol doi: 10.1530/EJE-21-0721 – volume: 396 start-page: 565 issue: 10250 year: 2020 ident: 5891_CR5 publication-title: Lancet doi: 10.1016/S0140-6736(20)31561-0 – volume: 7 start-page: 669 issue: 4 year: 2019 ident: 5891_CR39 publication-title: Sex Med Rev doi: 10.1016/j.sxmr.2019.06.006 – volume: 42 start-page: 635 issue: 4 year: 2019 ident: 5891_CR11 publication-title: Diabetes Care doi: 10.2337/dc18-2029 – volume: 66 start-page: 213 issue: 1 year: 2023 ident: 5891_CR40 publication-title: Diabetologia doi: 10.1007/s00125-022-05790-7 – volume: 100 start-page: 1646 issue: 4 year: 2015 ident: 5891_CR99 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2014-3761 – volume: 27 start-page: 479 issue: 5 year: 2013 ident: 5891_CR107 publication-title: J Diabetes Complicat doi: 10.1016/j.jdiacomp.2013.04.012 – volume: 84 start-page: 104259 year: 2022 ident: 5891_CR34 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2022.104259 – volume: 34 start-page: 309 issue: 3 year: 2013 ident: 5891_CR36 publication-title: Endocr Rev doi: 10.1210/er.2012-1055 – volume: 60 start-page: 240 issue: 2 year: 2017 ident: 5891_CR19 publication-title: Diabetologia doi: 10.1007/s00125-016-4162-6 – volume: 131 start-page: 230 year: 2017 ident: 5891_CR62 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2017.07.012 – volume: 17 start-page: 533 issue: 6 year: 2015 ident: 5891_CR128 publication-title: Diabetes, Obes Metab doi: 10.1111/dom.12449 – volume: 41 start-page: 211 issue: 2 year: 2018 ident: 5891_CR134 publication-title: Clin Cardiol doi: 10.1002/clc.22917 – volume: 4 start-page: e216139 issue: 4 year: 2021 ident: 5891_CR103 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2021.6139 – ident: 5891_CR35 doi: 10.2337/dc22-S004 – volume-title: IDF Diabetes Atlas year: 2021 ident: 5891_CR1 – volume: 36 start-page: 3128 issue: 10 year: 2013 ident: 5891_CR18 publication-title: Diabetes Care doi: 10.2337/dc13-0219 – volume: 169 start-page: 108452 year: 2020 ident: 5891_CR88 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2020.108452 – volume: 22 start-page: 83 issue: 2 year: 2008 ident: 5891_CR91 publication-title: J Diabetes Complications doi: 10.1016/j.jdiacomp.2007.06.009 – volume: 17 start-page: 47 issue: 1 year: 2021 ident: 5891_CR7 publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-020-00431-8 – volume: 19 start-page: 154 issue: 1 year: 2020 ident: 5891_CR115 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-020-01133-1 – volume: 22 start-page: 263 issue: 2 year: 2020 ident: 5891_CR104 publication-title: Diabetes, Obes Metab doi: 10.1111/dom.13876 – volume: 9 start-page: 1969 issue: 5 year: 2018 ident: 5891_CR118 publication-title: Diabetes Ther doi: 10.1007/s13300-018-0492-3 – volume: 37 start-page: 1344 issue: 9-10 year: 2020 ident: 5891_CR58 publication-title: Chronobiol Int doi: 10.1080/07420528.2020.1804923 – volume: 31 start-page: 1121 issue: 9 year: 2014 ident: 5891_CR89 publication-title: Diabet Med doi: 10.1111/dme.12478 – volume: 141 start-page: 338 issue: 5 year: 2020 ident: 5891_CR138 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.119.044491 – volume: 381 start-page: 1609 issue: 17 year: 2019 ident: 5891_CR137 publication-title: N Engl J Med doi: 10.1056/NEJMoa1908655 – volume: 8 start-page: 608083 year: 2021 ident: 5891_CR120 publication-title: Front Med (Lausanne) doi: 10.3389/fmed.2021.608083 – volume: 10 start-page: 17545 issue: 1 year: 2020 ident: 5891_CR127 publication-title: Sci Rep doi: 10.1038/s41598-020-74000-4 – volume: 62 start-page: 1550 issue: 9 year: 2019 ident: 5891_CR73 publication-title: Diabetologia doi: 10.1007/s00125-019-4926-x – volume: 62 start-page: 1854 issue: 10 year: 2019 ident: 5891_CR109 publication-title: Diabetologia doi: 10.1007/s00125-019-4955-5 – volume: 385 start-page: 1397 issue: 9976 year: 2015 ident: 5891_CR129 publication-title: Lancet doi: 10.1016/S0140-6736(14)61368-4 – volume: 319 start-page: 1185 issue: 12 year: 2018 ident: 5891_CR16 publication-title: JAMA doi: 10.1001/jama.2018.0423 – volume: 68 start-page: 655 issue: 6 year: 2021 ident: 5891_CR83 publication-title: Endocr J doi: 10.1507/endocrj.EJ20-0630 – volume: 26 start-page: 61 issue: 1 year: 2003 ident: 5891_CR2 publication-title: Diabetes Care doi: 10.2337/diacare.26.1.61 – volume: 107 start-page: e899 issue: 3 year: 2022 ident: 5891_CR42 publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgab757 – volume: 10 start-page: 795 issue: 11 year: 2022 ident: 5891_CR3 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(22)00252-2 – volume: 171 start-page: 108625 year: 2021 ident: 5891_CR47 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2020.108625 – volume: 5 start-page: 19 issue: 3 year: 2020 ident: 5891_CR76 publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2019.5306 – volume: 240 start-page: R97 issue: 3 year: 2019 ident: 5891_CR38 publication-title: J Endocrinol doi: 10.1530/JOE-18-0573 – volume: 30 start-page: 686 issue: 4 year: 2016 ident: 5891_CR113 publication-title: J Diabetes Complications doi: 10.1016/j.jdiacomp.2016.01.013 – volume: 12 start-page: 23 issue: 1 year: 2021 ident: 5891_CR6 publication-title: Biol Sex Differ doi: 10.1186/s13293-021-00366-3 – volume: 55 start-page: 1832 issue: 6 year: 2006 ident: 5891_CR81 publication-title: Diabetes doi: 10.2337/db05-1620 – volume: 27 start-page: 58 issue: 1 year: 2021 ident: 5891_CR25 publication-title: Nat Med doi: 10.1038/s41591-020-1126-7 – volume: 38 start-page: e14395 issue: 8 year: 2021 ident: 5891_CR94 publication-title: Diabet Med doi: 10.1111/dme.14395 – volume: 146 start-page: 1046 issue: 14 year: 2022 ident: 5891_CR105 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.122.059755 – volume: 46 start-page: 608 issue: 5 year: 2003 ident: 5891_CR69 publication-title: Diabetologia doi: 10.1007/s00125-003-1096-6 – volume: 29 start-page: 1909 issue: 8 year: 2006 ident: 5891_CR31 publication-title: Diabetes Care doi: 10.2337/dc06-0438 – volume: 78 start-page: 1706 issue: 12 year: 2019 ident: 5891_CR119 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2019-215714 – volume: 12 start-page: 392 year: 2012 ident: 5891_CR51 publication-title: BMC Public Health doi: 10.1186/1471-2458-12-392 – volume: 9 start-page: e012940 issue: 1 year: 2020 ident: 5891_CR102 publication-title: J Am Heart Assoc doi: 10.1161/JAHA.119.012940 – volume: 34 start-page: 1508 issue: 11 year: 2017 ident: 5891_CR63 publication-title: Diabet Med doi: 10.1111/dme.13448 – volume: 180 start-page: 41 issue: 1 year: 2019 ident: 5891_CR37 publication-title: Eur J Endocrinol doi: 10.1530/EJE-18-0602 – volume: 41 start-page: 1346 issue: 13 year: 2020 ident: 5891_CR68 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehz913 – volume: 17 start-page: 198 issue: 1 year: 2019 ident: 5891_CR136 publication-title: BMC Med doi: 10.1186/s12916-019-1428-0 – volume: 534 start-page: 111365 year: 2021 ident: 5891_CR24 publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2021.111365 – volume: 190 start-page: 110027 year: 2022 ident: 5891_CR13 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2022.110027 – volume: 63 start-page: 453 issue: 3 year: 2020 ident: 5891_CR14 publication-title: Diabetologia doi: 10.1007/s00125-019-05040-3 – volume: 37 start-page: 3106 issue: 11 year: 2014 ident: 5891_CR101 publication-title: Diabetes Care doi: 10.2337/dc14-1306 – volume: 139 start-page: 2742 issue: 24 year: 2019 ident: 5891_CR66 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.039100 – volume: 96 start-page: 515 issue: 2 year: 2011 ident: 5891_CR30 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-1398 – volume: 93 start-page: 4774 issue: 12 year: 2008 ident: 5891_CR48 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2008-0772 – volume: 130 start-page: 5688 issue: 11 year: 2020 ident: 5891_CR20 publication-title: J Clin Invest doi: 10.1172/JCI140223 – volume: 52 start-page: 244 issue: 2 year: 2003 ident: 5891_CR27 publication-title: Diabetes doi: 10.2337/diabetes.52.2.244 – volume: 9 start-page: 32 issue: 1 year: 2021 ident: 5891_CR43 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(20)30367-3 – volume: 14 start-page: 181 issue: 3 year: 2020 ident: 5891_CR114 publication-title: Diabetes Metab Syndr doi: 10.1016/j.dsx.2020.02.012 – volume: 37 start-page: 29 issue: 1 year: 2020 ident: 5891_CR59 publication-title: Chronobiol Int doi: 10.1080/07420528.2019.1683570 – volume: 21 start-page: 279 issue: 1 year: 2022 ident: 5891_CR72 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-022-01713-3 – volume: 17 start-page: 136 issue: 1 year: 2019 ident: 5891_CR85 publication-title: BMC Med doi: 10.1186/s12916-019-1355-0 – volume: 43 start-page: 1157 issue: 5 year: 2020 ident: 5891_CR70 publication-title: Diabetes Care doi: 10.2337/dc19-2257 – volume: 9 start-page: 220 year: 2018 ident: 5891_CR93 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2018.00220 – volume: 2018 start-page: 5406128 year: 2018 ident: 5891_CR28 publication-title: Int J Endocrinol doi: 10.1155/2018/5406128 – volume: 55 start-page: 627 issue: 6 year: 2018 ident: 5891_CR57 publication-title: Acta Diabetol doi: 10.1007/s00592-018-1132-0 – volume: 55 start-page: 66 issue: 1 year: 2017 ident: 5891_CR80 publication-title: Endocrine doi: 10.1007/s12020-016-1014-6 – volume: 16 start-page: e0243797 issue: 3 year: 2021 ident: 5891_CR87 publication-title: PLoS One doi: 10.1371/journal.pone.0243797 – volume: 103 start-page: e7 issue: 3 year: 2014 ident: 5891_CR92 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2013.12.043 – volume: 26 start-page: 1080 issue: 10 year: 2019 ident: 5891_CR32 publication-title: Eur J Prev Cardiol doi: 10.1177/2047487319834396 – volume: 387 start-page: 1089 issue: 12 year: 2022 ident: 5891_CR106 publication-title: N Engl J Med doi: 10.1056/NEJMoa2206286 – volume: 9 start-page: 1689 issue: 4 year: 2018 ident: 5891_CR124 publication-title: Diabetes Ther doi: 10.1007/s13300-018-0470-9 – volume: 64 start-page: 553 issue: 5 year: 2017 ident: 5891_CR112 publication-title: Endocr J doi: 10.1507/endocrj.EJ16-0552 – volume: 17 start-page: 468 issue: 7 year: 2015 ident: 5891_CR126 publication-title: Diabetes Technol Ther doi: 10.1089/dia.2014.0412 – volume: 6 start-page: 123 year: 2013 ident: 5891_CR111 publication-title: Diabetes Metab Syndr Obes doi: 10.2147/dmso.S42729 – volume: 18 start-page: e270821195904 issue: 6 year: 2022 ident: 5891_CR86 publication-title: Curr Diabetes Rev doi: 10.2174/1573399817666210827121937 – volume: 45 start-page: 1038 issue: 5 year: 2021 ident: 5891_CR50 publication-title: Diabetes Care doi: 10.2337/dc21-1071 – volume: 7 start-page: 1013 issue: 10 year: 2014 ident: 5891_CR130 publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2014.04.019 – volume: 332 start-page: 73 issue: 7533 year: 2006 ident: 5891_CR64 publication-title: BMJ doi: 10.1136/bmj.38678.389583.7C – volume: 5 start-page: 839 issue: 11 year: 2017 ident: 5891_CR54 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(17)30336-4 – volume: 29 start-page: 1997 issue: 9 year: 2006 ident: 5891_CR96 publication-title: Diabetes Care doi: 10.2337/dc06-0454 – volume: 14 start-page: 101 year: 2015 ident: 5891_CR52 publication-title: Int J Equity Health doi: 10.1186/s12939-015-0245-0 – volume: 5 start-page: 47 issue: 1 year: 2019 ident: 5891_CR46 publication-title: Nat Rev Dis Primers doi: 10.1038/s41572-019-0098-8 – volume: 36 start-page: 2683 issue: 9 year: 2013 ident: 5891_CR56 publication-title: Diabetes Care doi: 10.2337/dc12-1738 – volume: 388 start-page: 103 year: 2018 ident: 5891_CR82 publication-title: J Neurol Sci doi: 10.1016/j.jns.2018.03.008 – volume: 37 start-page: 278 issue: 3 year: 2016 ident: 5891_CR4 publication-title: Endocr Rev doi: 10.1210/er.2015-1137 – volume: 71 start-page: A1077 issue: 11_Supplement year: 2018 ident: 5891_CR131 publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(18)31618-8 – volume: 20 start-page: 409 issue: 2 year: 2018 ident: 5891_CR110 publication-title: Diabetes Obes Metab doi: 10.1111/dom.13086 – volume: 6 start-page: 538 issue: 7 year: 2018 ident: 5891_CR65 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(18)30079-2 – volume: 60 start-page: 1385 issue: 8 year: 2017 ident: 5891_CR108 publication-title: Diabetologia doi: 10.1007/s00125-017-4301-8 – volume: 294 start-page: R1220 issue: 4 year: 2008 ident: 5891_CR133 publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00864.2007 – volume: 65 start-page: 226 issue: 1 year: 2022 ident: 5891_CR26 publication-title: Diabetologia doi: 10.1007/s00125-021-05583-4 – volume: 14 start-page: 270 issue: 5 year: 2018 ident: 5891_CR41 publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2018.24 – volume: 33 start-page: 1113 issue: 11 year: 2018 ident: 5891_CR21 publication-title: Eur J Epidemiol doi: 10.1007/s10654-018-0433-5 – volume: 275 start-page: 1557 issue: 20 year: 1996 ident: 5891_CR75 publication-title: JAMA doi: 10.1001/jama.1996.03530440037034 – volume: 66 start-page: 321 issue: 2 year: 2023 ident: 5891_CR23 publication-title: Diabetologia doi: 10.1007/s00125-022-05811-5 – volume: 175 start-page: 665 issue: 5 year: 2022 ident: 5891_CR122 publication-title: Ann Intern Med doi: 10.7326/M21-4389 – volume: 19 start-page: 153 issue: 3 year: 2022 ident: 5891_CR29 publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-021-00551-0 – volume: 138 start-page: 198 issue: 2 year: 2018 ident: 5891_CR77 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.034271 – volume: 62 start-page: 1420 issue: 8 year: 2019 ident: 5891_CR53 publication-title: Diabetologia doi: 10.1007/s00125-019-4896-z – volume: 370 start-page: m2297 year: 2020 ident: 5891_CR33 publication-title: BMJ doi: 10.1136/bmj.m2297 – volume: 25 start-page: 1657 issue: 11 year: 2019 ident: 5891_CR78 publication-title: Nat Med doi: 10.1038/s41591-019-0643-8 – volume: 170 start-page: 764 issue: 11 year: 2019 ident: 5891_CR125 publication-title: Ann Intern Med doi: 10.7326/M19-0085 – volume: 119 start-page: 195 year: 2017 ident: 5891_CR123 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2017.01.023 – reference: 37042956 - Diabetologia. 2023 Jun;66(6):1165. doi: 10.1007/s00125-023-05913-8. |
| SSID | ssj0003546 |
| Score | 2.7329795 |
| SecondaryResourceType | review_article |
| Snippet | The prevalence of type 2 diabetes mellitus is increasing in both sexes, but men are usually diagnosed at a younger age and lower body fat mass than women.... |
| SourceID | pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 986 |
| SubjectTerms | Body fat Cardiovascular diseases Cardiovascular Diseases - epidemiology Comorbidity Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - epidemiology Diagnosis Female Gender Gender differences Gestational diabetes Glucose metabolism Human Physiology Humans Internal Medicine Life span Male Medicine Medicine & Public Health Menopause Metabolic Diseases Obesity Obesity - complications Obesity - epidemiology Pregnancy complications Prevalence Review Risk Factors Sex Characteristics Sex differences Sex Factors Social interactions Women |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9MwFH9iLZp2Gd8sMFBA3Ia1OLZj-4QGasUBqoqPqbfIsR1RCaXb2k7982e7TqquoheusaPEfs_PP72P3wP4YA2hRcUwMlgbRJkkSGY2RziwndNMs0D2fPmNj0ZiMpHj6HCbx7TK1iYGQ21m2vvIz3PhsEyBRUY_XV0j3zXKR1djC40D6HumMtqD_ufBaPyjs8Ukluo4M4ywKCaxbCYUz_mHvjrZ568JidFq-2rawZu7aZP3YqfhSho--t_FPIbjCEbTi7X2PIEHtnkKh99juP0ZvP9pV2nbQsUZlHTapN5nm-Zp67N9Dr-Hg19fvqLYVAFpytkCVSxXDkSRWjKJNdWGWmoqVVSSFErnmDiAaIgVltSWkIoVwjJWKypsrRyUNOQF9JpZY08gVXnFtVFMaV5TVXAlFBdaWJsVmZE1TQC3-1nqyDjuG1_8LTuu5CCD0smgDDIoVwmcde9crfk29s4-bfe3jGdvXm42N4F33bA7NT4Uoho7W7o5XHimPcFEAi_XUu0-55RUcuJHxJa8uwmekXt7pJn-Cczc3hVCHKZO4GOrGpv_-vcyXu1fxms4yoOaet_PKfQWN0v7Bh7q28V0fvM2qvwdBpQF_w priority: 102 providerName: ProQuest |
| Title | Sex differences in type 2 diabetes |
| URI | https://link.springer.com/article/10.1007/s00125-023-05891-x https://www.ncbi.nlm.nih.gov/pubmed/36897358 https://www.proquest.com/docview/2809961804 https://www.proquest.com/docview/2786095858 https://pubmed.ncbi.nlm.nih.gov/PMC10163139 |
| Volume | 66 |
| WOSCitedRecordID | wos000947275800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1432-0428 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0003546 issn: 0012-186X databaseCode: 7X7 dateStart: 20230101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1432-0428 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0003546 issn: 0012-186X databaseCode: BENPR dateStart: 20230101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1432-0428 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0003546 issn: 0012-186X databaseCode: 8C1 dateStart: 20230101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1432-0428 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0003546 issn: 0012-186X databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xEuqltDzaLXSVot6KpTi24_GxIBAHWCFe2lvk2I5YCWURu1T8_NreJGiBVoKLL54knozH_jTj-Qzw01nG81JQYqmxhAvFiEpdRmhkO-epEZHs-fpEDgY4HKqzpihs0p52b1OScaXuit3CzhyqicN5M1SUeOS47Lc7DO54fnHdrb-sKc_x4oRiPmxKZV5_x_x29AJjvjwq-SxfGreho7X3KfAJPjawM_k9myefYcHV67B62iTWN2D3wj0m7WUpfulIRnUSorNJlrTR2U24Ojq8PDgmzfUJxHAppqQUmfZwiVVKKGq4sdxxW-q8VCzXJqPMQ0HLHDpWOcZKkaMTotIcXaU9aLRsC5bqce2-QqKzUhqrhTay4jqXGrVEg86leWpVxXtA279YmIZbPFxxcVt0rMhR-cIrX0Tli8ce_OqeuZsxa_xXeqc1TtF42aTI0OPbnGLqB_Cj6_b-EZIeunbjBy8jMXDqocAefJnZsvucn45KstCDc1buBAL39nxPPbqJHNwh6ME8eu7BXmvsp3H9W41vbxPfhg9ZnC8h6rMDS9P7B_cdVsyf6Why34dFOZSxRd_iAe3D8v7h4Oy8Hx3iL1R4_4M |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgigX3oVAgYDgVCziV2IfEEKFqlW3KyQK2ltwbEeshLKlu4XlT_Eb8XiTrJaK3nrgGjuJ7Xl4PJ75BuC5d1zklaTEUeuIkJoTnXlGaEQ7F5mVEez586AYDtVopD-swe8uFwbDKjudGBW1m1j0kb9iKtgyOVWZeHP8nWDVKLxd7UpoLNjiwP_6GY5s09f77wJ9XzC2-_5oZ4-0VQWIFYWckUoyE6wIXmupqRXWCS9cZfJK89xYRnmwkBz3yvPac17JXHkpayOUr02wpRwP370ElxHJDg97amcZUsLbxKCg9AlV-ahN0ompevgQc6ExWk5pSuarG-EZ6_ZskOZfN7VxA9y98b8t3U243pra6duFbNyCNd_chquHbTDBHXj20c_TrkBMUJfpuEnRI52ytPNI34VPFzLCTVhvJo2_D6lhVWGdkcYWtTB5YZQplFXeZ3nmdC0SoB39StviqWNZj29ljwQdaV4GmpeR5uU8ge3-neMFmsi5vbc6epatZpmWS2Im8LRvDjoBL3pM4yenoU-hEEdQSZXAvQUX9b8LIqgLji1qhb_6Dog3vtrSjL9G3HF09PBwYkjgZceKy3H9exoPzp_GE9jYOzoclIP94cFDuMaiiKCXawvWZyen_hFcsT9m4-nJ4yhsKXy5aBb9A9bcYjw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VFlVcoAUKgRYCghO1Gr9i-4AQalm1allV4qG9pY7tqCtV2dLdwvLX-HXY3iSrbUVvPXCNncT2PDwez3wD8MZZyvKSY2SxsYhxRZHKHEE4op2zzPAI9vz9SPT7cjBQx0vwp82FCWGVrU6MitqOTPCR7xDpbZkcy4ztVE1YxPFe78P5DxQqSIWb1racxoxFDt3vX_74Nn5_sOdp_ZaQ3qevu_uoqTCADBN8gkpOtLcoaKW4woYZyxyzpc5LRXNtCKbeWrLUSUcrR2nJc-k4rzSTrtLerrLUf_cOrAjquThkqe_Ow0tokyTkNwCEZT5oEnZi2l54GPKiQ-ScVBhNFzfFa5bu9YDNK7e2cTPsPfifl3EN7jcmePpxJjPrsOTqh7D6uQkyeASvv7hp2haO8Wo0HdZp8FSnJG091Y_h262McAOW61HtnkKqSSmM1VwbUTGdCy21kEY6l-WZVRVLALe0LEyDsx7KfZwVHUJ0pH_h6V9E-hfTBN5175zPUEZu7L3Z0rZoNM64mBM2gVdds9cV4QJI12506fsIGfAFJZcJPJlxVPc7L5pK0NAiF3it6xBwyBdb6uFpxCMPDiDqTxIJbLdsOR_Xv6fx7OZpvIRVz5nF0UH_8DncI1FagvNrE5YnF5duC-6an5Ph-OJFlLsUTm6bQ_8CzFNrAQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sex+differences+in+type+2+diabetes&rft.jtitle=Diabetologia&rft.au=Kautzky-Willer%2C+Alexandra&rft.au=Leutner%2C+Michael&rft.au=Harreiter%2C+J%C3%BCrgen&rft.date=2023-06-01&rft.issn=1432-0428&rft.eissn=1432-0428&rft.volume=66&rft.issue=6&rft.spage=986&rft_id=info:doi/10.1007%2Fs00125-023-05891-x&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-186X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-186X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-186X&client=summon |